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ABSTRACT

Boesche, Katherine E. Ph.D., Purdue University, December 2015. Control of bovine
pyruvate carboxylase expression by saturated and unsaturated fatty acids and impact on
fatty acid metabolism. Major Professor: Shawn S Donkin.

Pyruvate carboxylase (PC; EC 6.4.1.1) ostensibly links carbohydrate and lipid
metabolism by supplying oxaloacetate (OAA) from the carboxylation of pyruvate. The
OAA pool is necessary in maintaining the anaplerotic supply of carbons to the TCA
cycle, and to promote the complete oxidation, to CO2, of acetyl-CoA. The actions of PC
in supplying OAA are critical during periods of increased cellular lipid load, including
the negative energy balance experienced by periparturient dairy cows. The bovine PC
gene contains three promoter sequences, with products of the proximal promoter (PCP1)
being specific to glucogenic and lipogenic tissues. Previous work links control of bovine
PC mRNA expression to nonesterified fatty acids (NEFA), but the direct effects of
saturated and unsaturated fatty acids on PC mRNA expression and subsequent fatty acid
metabolism were unclear. The central hypothesis of this dissertation is that the ratio of
the most prevalent circulating saturated and unsaturated fatty acids in dairy cows
regulates PC flux and subsequent fatty acid metabolism. The objectives of this
dissertation were, first, to evaluate the response of PC mRNA to the copresence of the
most abundant circulating saturated and unsaturated fatty acids in periparturient dairy
cows. Second, to determine the direct effects of these saturated and unsaturated fatty
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acids, and their combinations, on the cellular oxidation of fatty acids, and the potential
relationship to PC, and third, to examine the effects of the copresence of saturated and
unsaturated fatty acids on the transcriptional activity of bovine PCP1.
Bovine PC mRNA expression was first examined, in response to copresence of
saturated and unsaturated fatty acids, in a bovine kidney cell line and in bovine primary
hepatocytes. Both C16:0 or C18:0 alone significantly depressed PC mRNA in bovine
kidney cells. Inclusion of unsaturated C18:3n-3 cis restored PC expression to levels
similar to control in bovine kidney cells. Data from bovine primary hepatocytes displayed
a similar numerical pattern in response to fatty acid combinations, although means did
not differ. However, incubation with C18:3n-3 cis alone resulted in nearly two-fold
increase in PC mRNA expression, compared to PC mRNA expression after control or
saturated fatty acid exposure. Treatment with monounsaturated C18:1n-9 cis did not alter
PC mRNA expression in either cell model. Results indicate that C18:3n-3 cis is a potent
alleviator of saturated fatty acid-induced depression of PC mRNA expression.
To determine the impact of alterations in PC mRNA expression on cellular
metabolism of fatty acids, the flux of radiolabeled C16:0 to CO2 or to acid-soluble
metabolites, including ketone bodies, was analyzed after pretreatment of bovine kidney
cells with combinations of saturated and unsaturated fatty acids which are most prevalent
in periparturient dairy cows. Prior exposure to either C16:0 or C18:0 alone significantly
depressed both complete and partial oxidation compared to exposure to C18:3n-3 alone.
Data for complete oxidation of radiolabeled C16:0 to CO2 were correlated (r = 0.63; P <
0.05) with PC mRNA expression, suggesting a potential relationship between PC flux
and subsequent fatty acid metabolism. Oxidation of radiolabeled C16:0 to CO2 was also
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correlated (r = 0.80; P < 0.05) to expression of cytosolic phosphoenolpyruvate
carboxykinase (PCK1). The data indicate that although PC is regulated by fatty acids and
in turn modulates the oxidation of fatty acids, the concomitant increase in PCK1 may
oppose these effects by pulling carbon from the OAA pool toward gluconeogenesis.
Factors remain to be identified that permit increased PC flux while maintaining, but not
enhancing, PCK1 flux.
The role of bovine PCP1 in regulating the expression of PC mRNA in response to
the copresence of saturated and unsaturated fatty acids prevalent in periparturient dairy
cows was evaluated using bovine PCP1 ligated to a Firefly luciferase reporter and
transiently transfected into bovine kidney cells. Bovine PCP1 activity increased in
response to either C16:0 or C18:3n-3 cis, and combinations of those fatty acids,
indicating a dominant role of C18:3n-3 cis in controlling bovine PCP1 activity.
Truncations of bovine PCP1 indicate a region responsive to fatty acids located between
-773 to -494 bp (PCP1(-773_+3)) relative to transcription start site (TSS), as activity in
response to fatty acid greatly diminished with truncation of this region. In silico analysis
of bovine PCP1 indicates several transcription factor binding site consensus sequences,
including peroxisome proliferator activated receptor (PPAR) α and sterol regulatory
element binding proteins (SREBP) sites, that are candidate response elements for control
by C18:3n-3 cis and C16:0 or C18:0. Results indicate a dominant role of C18:3n-3 cis to
signal through bovine PCP1(-773_+3) containing a PPARα binding site. A SREBP binding
site within bovine PCP1(-773_+3) is a candidate for saturated fatty acid responsiveness
within this promoter region.

xviii
Together, these data indicate control by saturated and unsaturated fatty acids
prevalent in periparturient bovine on PC mRNA expression, regulated through the PC
proximal promoter, and in determining subsequent cellular fatty acid metabolism.
Responsiveness of bovine PCP1 to saturated and unsaturated fatty acids may be mediated
through identified putative binding sites. The cellular oxidative capacity, dependent upon
the pool of OAA generated by PC, can help determine the response to physiological
factors, including fatty acids, which increase during metabolically stressful periods in
dairy cows.
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CHAPTER 1. LITERATURE REVIEW

INTRODUCTION

First discovered for its role in gluconeogenesis in chicken liver (Utter and Keech,
1960), pyruvate carboxylase (PC; EC 6.4.1.1) is a mitochondrial enzyme central to
several metabolic pathways. Pyruvate carboxylase is responsible for the irreversible,
ATP-dependent carboxylation of pyruvate to oxaloacetate (OAA; Utter and Keech,
1960). Oxaloacetate supply by PC is inextricably linked to the activity of the
tricarboxylic acid (TCA) cycle, which functions to oxidize acetyl-CoA to CO2 and
provide intermediates for several other biological pathways. The flux of carbons into, and
maintenance of the TCA cycle biological intermediates, is referred to as anaplerosis
(Kornberg, 1966; Owen et al., 2002). The anaplerotic role of PC in catalyzing OAA
synthesis from pyruvate, is therefore evident. The reciprocal pull of carbons away from
the TCA cycle, or cataplerosis, links products of the TCA cycle to several biosynthetic
pathways, including fatty acid synthesis, gluconeogenesis, and glyceroneogenesis (Owen
et al., 2002). Because the TCA cycle cannot serve as a carbon sink, cataplerotic enzymes,
including phosphoenolpyruvate carboxykinase (PCK; EC 4.1.1.32), become especially
critical during periods of increased energy intake (Owen et al., 2002). Without increased
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cataplerotic pull, the anaplerotic action of PC could function to increase the oxidative
capacity of the TCA cycle, increasing the oxidation of acetyl-CoA.
Regulation of PC by circulating fatty acids has been extensively explored in both
human and murine models (Jitrapakdee et al., 2008; Gray et al., 2014), and recently
explored in bovine (White et al. 2011b,c; White et al., 2012). A direct relationship
between PC activity and influences of specific fatty acids has yet to be fully elucidated.
This review will focus on the regulation and anaplerotic roles of PC, examine the
potential influences of circulating fatty acids, and stress the significance of these roles in
ruminant animals.

PYRUVATE CARBOXYLASE

Enzyme structure
The mammalian PC enzyme, found in the mitochondrial matrix, consists of four
identical subunits, each of approximately 120 – 130 kDa. These subunits are arranged as
dimers of dimers in a homotetrameric structure. The PC enzyme is only active in this
tetrameric structure (Jitrapakdee et al., 2008; Gray et al., 2014). Similar to other biotindependent enzymes, PC contains three functional domains: an N-terminal domain with a
biotin carboxylation site, a central domain with a carboxyltransferase site, and a Cterminus domain containing the biotin carboxyl carrier protein unit (St. Maurice et al.,
2007). A prosthetic biotin group is covalently bound to a specific lysine residue within
the carrier protein unit (Jitrapakdee and Wallace, 1999). Pyruvate carboxylase shows a
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high degree of structural similarity to other biotin-dependent enzymes, including
propionyl-CoA carboxylase (PCC; EC 6.4.1.3), and acetyl-CoA carboxylase (ACC; EC
6.4.1.2; Jitrapakdee et al., 2008).

Enzyme function
Conversion of pyruvate to OAA by PC occurs over two spatially separate enzyme
subsites. This reaction is catalyzed in two steps with biotin acting as the carboxyl carrier.
The first, ATP-dependent step involves carboxylation of biotin with a CO2 from HCO3-,
via the formation of a carboxyphosphate intermediate (Attwood, 1995; Jitrapakdee and
Wallace, 1999; Gray et al., 2014). The carboxybiotin group is then transferred to the PC
carboxyltransferase site where the carboxyl group is transferred from carboxybiotin to
pyruvate, resulting in OAA and a regeneration of the biotin cofactor (Jitrapakdee and
Wallace, 1999; Gray et al., 2014). Requirements for ATP, acetyl-CoA, and Mg2+, for the
reaction to proceed were identified very early on (Utter and Keech, 1960). The role of
Mg2+ as an essential cofactor was later confirmed through several kinetic studies to
identify Mg2+ binding sites (Attwood and Graneri, 1992). Necessity of acetyl-CoA as an
allosteric activator of PC is now well established (review by Adina-Zada et al., 2012).
Binding of acetyl-CoA drastically alters both the structure and catalytic activity of PC
through stabilization of the tetrameric structure of the enzyme and enhancement of
substrate binding to HCO3- (Adina-Zada et al., 2012). The major influence of acetyl-CoA
is only the first partial reaction carried out by PC, and the allosteric binding site of acetylCoA between the different domain sites has been identified (St. Maurice et al., 2007).
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ROLE OF PYRUVATE CARBOXYLASE IN METABOLISM

Anaplerotic Roles of Pyruvate Carboxylase
Pyruvate carboxylase was initially identified, along with fructose-1,6bisphosphtase (F1,6BPase; EC 3.1.3.11), glucose-6-phosphatase (G6Pase; EC 3.1.3.9),
and PCK, as one of the four primary gluconeogenic enzymes (Utter and Keech, 1960).
More recently, PC has been described as the “archetypical anaplerotic enzyme” for its
fundamental role in replenishing OAA supply to the TCA cycle (Owen et al., 2002). The
limiting factor for TCA cycle capacity is the pool of OAA, and while this pool is utilized
for several biological endpoints, discussed below, the pull of carbon intermediates out of
the TCA cycle must be concurrently coupled with OAA supply. Any biochemical
pathway that begins with an intermediate of the TCA cycle relies on the anaplerotic
replenishment of TCA cycle intermediates, in part by PC, to promote flow through the
pathway (Figure 1.1).

Overview of Tricarboxylic acid cycle
The TCA cycle is common to all aerobic organisms and generates energy through
the oxidation of carbon fuel sources to generate reducing equivalents, which will in turn
be utilized to generate ATP through oxidative phosphorylation. The essentiality of the
TCA cycle in many biochemical pathways across a variety of organisms illustrates its
conservation through evolution. In eukaryotes, acetyl-CoA, produced from the catabolism
of amino acid carbons, carbohydrates, and lipids, is oxidized in the mitochondria,
yielding three equivalents of NADH, one equivalent of FADH2, and one equivalent of
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GTP per acetyl-CoA equivalent. The NADH and FADH2 produced are subsequently
utilized, through oxidative phosphorylation, to generate ATP. The initial reaction of the
TCA cycle involves the condensation of 4-carbon OAA with 2-carbon acetyl-CoA and is
catalyzed by citrate synthase (EC 2.3.3.1; Remington, 1992). This is the first of three
exergonic reactions of the TCA cycle. Binding of OAA to citrate synthase induces a
conformational change in the enzyme, only then exposing the binding site for acetyl-CoA
(Remington, 1992). The need for the pool of OAA to drive the reaction is again
emphasized here. Subsequent dehydrogenation and decarboxylation reactions yield the
byproducts of two CO2 molecules, and the regeneration of OAA (Figure 1.1; Berg et al.,
2002).
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Figure 1.1. Anaplerotic and cataplerotic pull of oxaloacetate (OAA) by pyruvate
carboxylase (PC) and phosphoenolpyruvate carboxykinase (PCK). Adapted from Burgess
et al., 2004. The oxidative capacity of the tricarboxylic acid (TCA) cycle is dependent
upon the ratio of acetyl-CoA to oxaloacetate (OAA). Activation of PC promotes
anaplerotic pull of carbons to OAA synthesis and promotes TCA oxidative capacity.
Dihydroxyacetone phosphate, DHAP; fructose-6-phosphatase, F6P; fructose 1, 6bisphosphate, FBP; glyceraldehyde-3-phosphate, G3P; glucose-6-phosphatase, G6P;
phosphoenolpyruvate, PEP.
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Regulation of Tricarboxylic acid cycle
Both entry into, and rate of, the TCA cycle are tightly controlled through the
actions of several enzymes which are regulated, in large part, by the cellular
concentrations of ATP and NADH. The first of three exergonic steps of the TCA cycle,
catalyzed by citrate synthase, was described above. The remaining exergonic steps
involve the enzymes isocitrate dehydrogenase (EC 1.1.1.42) and α-ketoglutarate
dehydrogenase (EC 1.2.4.2; Berg et al., 2002). Substrate availability for citrate synthase
of either OAA or acetyl-CoA can vary under different metabolic circumstances. Increases
in the ratio of the concentrations of NADH and NAD+ can lead to negative feedback of
both isocitrate dehydrogenase and α-ketoglutarate dehydrogenase, as can increases in
ATP levels (Williamson and Cooper, 1980; Berg et al., 2002). An increased NADH to
NAD+ ratio would also indicate a decreased concentration of OAA, decreasing flux into
the initial cycle reaction. Additionally, ADP acts as an allosteric activator of isocitrate
dehydrogenase by enhancing substrate affinity (Berg et al., 2002). Such tight allosteric
regulations by reaction products allows for acute and rapid response to energy status
changes within the cell. Deficiency of α-ketoglutarate dehydrogenase is a very rare
autosomal recessive trait that presents with hypotonia, encephalopathy, and failure to
thrive; no specific treatment is available (Pithukpakorn, 2005). Such dramatic alterations
to metabolism illustrate the central role of this enzyme and the TCA cycle. The role of
PC in several aberrant metabolic systems is discussed in depth in subsequent sections.
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Substrates of Tricarboxylic acid cycle
Substrate flow into the TCA cycle increases during the fed state when metabolism
of glucose to pyruvate is increased. During the postprandial period, glucose enters
hepatocytes via the GLUT2 glucose transporter and is immediately phosphorylated by
glucokinase to glucose-6-phosphate. Gluconeogenesis and the cataplerotic role of
pyruvate carboxylase will be discussed in detail below. In brief, glucose-6-phosphate can
either be stored as glycogen or metabolized to pyruvate, potentially supplying this
substrate to PC for carboxylation to OAA (Rui, 2014). Linking cytosolic pyruvate
metabolism to the TCA cycle, the mitochondrial pyruvate carrier functions to transport
pyruvate from the mitochondrial intermembrane space to the mitochondrial matrix (Gray
et al., 2014; Patel et al., 2014). During the fed state, at least in nonruminants, most
pyruvate (with NAD+) is converted by the pyruvate dehydrogenase complex (PDC) to
acetyl-CoA, NADH, and CO2, with generated acetyl-CoA subsequently entering the TCA
cycle (Berg et al., 2002). Acetyl-CoA may also be utilized in other biochemical reactions,
including generation of acetylcholine, cholesterol formation, or lipogenesis. The PDC is
very tightly regulated by the energy status by the cell and is inhibited during high energy
status, when acetyl-CoA, ATP, or NADH levels increase (Gray et al., 2014). Regulation
of PDC occurs through transcriptional abundance of the proteins comprising the complex,
or acutely through phosphorylation and dephosphorylation by pyruvate dehydrogenase
kinases (PDK) and pyruvate dehydrogenase phosphatases (PDP), respectively.
Phosphorylation of specific residues on PDC subunits by PDK allow for rapid
downregulation of PDC in response to cellular energy levels. For example, during
fasting, activity of PDC can be repressed to promote the flux of pyruvate to other cellular
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fates. Pyruvate dehydrogenase phosphatase functions to dephosphorylate and activate
PDC to increase the flux of acetyl-CoA to the TCA cycle. Pyruvate dehydrogenase
phosphatase is activated by insulin and AMP, and inhibited by acetyl-CoA, ATP, and
NADH (Gray et al., 2014).
Because the supply of both acetyl-CoA and OAA regulate substrate availability
for PC, both pools must be taken into consideration when investigating the anaplerotic or
cataplerotic roles of PC. The anaplerotic activity of PC, through the generation of OAA
from pyruvate, serves to offset the cataplerotic pull of carbons from the TCA cycle. The
ratio of acetyl-CoA to OAA must remain equal if activity of the TCA cycle to completely
oxidize acetyl-CoA is to be maintained (White, 2015). The circulating fatty acid profile
both supplies acetyl-CoA from fatty acid β-oxidation, and serves as signaling molecules
to regulate both gene expression and cellular metabolism. Increases in the oxidative
capacity of the TCA cycle, through increased PC flux would allow lactating dairy cows
to better cope with the increased plasma nonesterified fatty acid (NEFA) load
experienced at calving.

Cataplerotic Roles of Pyruvate Carboxylase
A primary role of PC involves supply of OAA for conversion to
phosphoenolpyruvate (PEP) by PCK (Figure 1.1). This cataplerotic pull of carbons away
from the TCA cycle and into other biochemical pathways in necessary to avoid the
excessive accumulation of ions in the mitochondrial matrix. Primary cataplerotic
pathways in which PC is critical include gluconeogenesis and synthesis of fatty acids.
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Gluconeogenesis: Overview and Regulation
Gluconeogenesis denotes the production of glucose, de novo, from noncarbohydrate precursors, including glucogenic amino acids, glycerol, lactate, and
propionate. Gluconeogenesis is critical in providing glucose to tissue with an obligatory
requirement for glucose, including the brain, erythrocytes, and mammary gland
(Aschenbach et al., 2010). Glucose supply from gluconeogenesis is critical during periods
when both dietary glucose and glycogen stores are expended, such as fasting or intense
exercise, in nonruminants, or at all times in ruminant animals (Aschenbach et al., 2010).
Liver and kidney are the major gluconeogenic tissues (Exton, 1972; Berg et al., 2002),
with recent research revealing small intestine as a third site of gluconeogenesis with
propionate, glycerol, and glutamine serving as gluconeogenic substrates (Croset et al.,
2011; De Vadder et al., 2014). The relative contribution of small intestine to whole-body
glucose production is still nominal in comparison to liver and kidney production. While
the process of gluconeogenesis does share the same pathway with glycolysis, the
thermodynamic barriers of irreversible reactions in glycolysis necessitate a separate set of
enzymes and leads to more than just a simple reversal of the steps to glycolysis.
Cellular transport systems allow entry of gluconeogenic precursors, namely
alanine, glycine, lactate, or serine, into the cytosol for conversion to pyruvate. In what is
the most widely known role for PC, pyruvate is converted to OAA in the mitochondria
(Berg et al., 2002), the first step in the conversion of pyruvate to PEP. This irreversible
step to gluconeogenesis requires two enzymes; the first, PC, and the second, PCK. The
decarboxylation of OAA to PEP by PCK requires GTP and is an endothermic process
(Berg et al., 2002). There are two isoforms of PCK; PCK1 is compartmentalized to the
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cytosol and PCK2 to the mitochondria (Hanson and Garber, 1972). The two PCK
isoforms are encoded by separate genes, but have highly similar kinetic characteristics
and in most species, including ruminants, activity of the two forms is equal (Hanson and
Garber, 1972; Hanson and Reshef, 1997). For conversion of OAA to PEP by PCK1,
OAA must first be transported to the cytosol. Because OAA cannot cross the
mitochondrial membrane, it is first converted to malate and aspartate. Malate and
aspartate are transported across the membrane of the mitochondrion and converted back
to OAA once in the cytosol. These reactions require NADH within the mitochondria and
NAD+ in the cytosol (Exton, 1972; Berg et al., 2002). Cytosolic OAA can then serve as a
substrate for PCK1 conversion to PEP. Conversion of OAA to PEP by PCK2 occurs in
the mitochondria (Berg et al., 2002). Deficiency of PCK1, even with maintained PCK2
activity, results in hepatic steatosis, hypoglycemia, and death before early childhood
(Vidnes and Sovik, 1976), illustrating the central metabolic role of the enzyme.
Subsequent reactions of gluconeogenesis require enzymes to overcome the kinetic
barriers of the glycolysis pathway. The actions of phophofructokinase in glycolysis are
circumvented by conversion of fructose 1,6-bisphosphate to fructose 6-phosphate by
fructose 1,6-bisphosphatase. Finally, glucose-6-phosphatase catalyzes the conversion of
glucose 6-phosphate to glucose, allowing for release of glucose to the blood stream (Berg
et al., 2002). The rate-limiting enzymes for gluconeogenesis are therefore PC, PCK,
fructose 1,6-bisphosphatase, and glucose-6-phosphatase. It is important to note that
glucose-6-phosphatase is only expressed in liver and kidney, and not muscle or adipose
tissue. This prevents substrate release from these glucose-utilizing, non-gluconeogenic
tissues (Exton, 1972). Furthermore, ruminant liver expresses hexokinase, rather than
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glucokinase. Hexokinase has a comparatively lower Km for glucose (Raggi et al., 1963;
Hayirli, 2006). This allows for the important distinction that glucose is not extracted, but
released from ruminant liver.

Gluconeogenesis in Ruminants
Nonruminants are supplied during the postprandial state through intestinal
absorption with large quantities of glucose. The main obstacle to overcome in
nonruminant glucose metabolism is maintaining glycogen stores after absorption, and
mobilization from these stores (Woerle et al., 2003). Gluconeogenesis from de novo
sources is only necessitated during fasting or under periods of increased glucose demand,
such as exercise. Microbial fermentation of fiber carbohydrates in the forestomach, or
rumen, of ruminant animals allows for the utilization of feedstuffs indigestible by
nonruminants. In functional ruminants, dietary carbohydrates are fermented to volatile
fatty acids (VFA), including propionate, leaving minimal amounts of exogenous glucose
available (Ballard et al., 1969; Reynolds et al., 1988). Very little glucose is therefore
presented for intestinal absorption, and ruminant glucose needs must be met through de
novo gluconeogenesis. In ruminants, propionate serves as the principal substrate for
gluconeogenesis (Reynolds et al., 2003). Furthermore, intestinal absorption of any
glucose present is extremely limited in ruminants (Mills et al., 1999). Therefore, by
necessity, over 90% of glucose requirements in ruminant animals is met through de novo
gluconeogenesis (Aschenbach et al., 2010).
The requirement for do novo gluconeogenesis is drastically augmented with the
onset of milk production during lactation in dairy cows. Lactose, the major milk osmole,
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depends on the availability of glucose as its major precursor during milk synthesis (Barry,
1964; Smith, 1971). Between 60-85% of total glucose requirements in lactating
ruminants can be attributed to lactose synthesis in mammary gland (Annison and Linzell,
1964). Splanchnic measurements have determined that the difference in glucose uptake
by mammary gland in lactating ruminants cannot be accounted for simply by increases in
glucose absorption across the portal-drained viscera (Doepel et al., 2009). Additionally,
studies utilizing isotope tracers have found that the rate of de novo glucose synthesis and
milk production in lactating dairy cows are positively correlated (Aschenbach et al.,
2010).

Gluconeogenic Precursors
Gluconeogenic amino acids, glycerol, lactate, and propionate serve as the
precursors for de novo gluconeogenesis. Ruminant gluconeogenesis is, in stark contrast to
gluconeogenesis in nonruminants, highest during the postprandial period when both the
production, and absorption, of propionate are increased (Reynolds et al., 2003).
Propionate serves as the primary precursor for do novo gluconeogenesis during the
postprandial state when the contribution from propionate is up to 60-80% (Annison and
Bryden, 1999; Aschenbach et al., 2010). Approximately 95% of propionate that is
absorbed from ruminal fermentation is subsequently converted to glucose, making this
process exceptionally efficient in ruminant animals (Steinhour and Bauman, 1988). In
contrast, de novo gluconeogenesis from propionate is dramatically decreased during
fasting, or during periods of imposed feed restriction (Lomax and Baird, 1983). After a
24 h fast, utilization of propionate by liver was decreased 80% and net glucose output
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decreased by 45% (Lomax and Baird, 1983). This lack of gluconeogenic precursors is
emphasized during the postpartum period when drastic glucose demands, accompanying
lactogenesis and lactose synthesis, are not met by feed intake (Bell, 1995). In turn,
gluconeogenesis from other precursors must increase to meet metabolic demands.
Contributions to de novo gluconeogenesis from lactate, gluconeogenic amino acids, and
glycerol range between 16-26%, 11-16%, and 0.5-3%, respectively (Aschenbach et al.,
2010). Mobilization of body fat reserves during periods of severe negative energy
balance, including the periparturient period in dairy cows, increase the availability of
fatty acids for metabolism in liver. Triglyceride degradation in liver supplies glycerol for
de novo gluconeogenesis. Approximately 15-20% of glucose requirements during these
periods can be met through mobilization of adipose tissue reserves (Bell, 1995).

Fatty Acid Synthesis
Synthesis of fatty acids, de novo, requires a carbon source to serve as the glycerol
backbone. Cytosolic citrate lyase (EC 4.1.3.8) catalyzes the cleavage of citrate, in the
presence of Coenzyme A and ATP, to OAA and acetyl-CoA. Fatty acid biosynthesis
utilizes this citrate cleavage as the initial step in fatty acid generation from acetyl-CoA
and malonyl-CoA precursors (Ballard and Hanson, 1967). Citrate formation from OAA is
dependent upon the pool of OAA generated by PC. For utilization in other biochemical
reactions, regenerated cytosolic OAA from the citrate lyase reaction would first need to
be converted to malate by malate dehydrogenase (EC 1.1.1.40), and then to pyruvate to
permit translocation into the mitochondria.
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In contrast, adipose tissue is the primary site of fatty acid synthesis in ruminants
(Ingle et al., 1972), where acetate utilization, compared to glucose substrate utilization, is
increased ten times over that in liver, adipose, and mammary gland of ruminants,
compared to nonruminants (Hanson and Ballard, 1967). Dramatically decreased
abundance of citrate lyase in ruminant liver prevents the citrate cleavage reaction to OAA
and acetyl-CoA (Hanson and Ballard, 1967; Ingle et al., 1972). Ruminant fatty acid
biosynthesis is supported, in large part, by acetyl-CoA synthase (EC 6.2.1.1), which
catalyzes the formation of acetate to acetyl-CoA (Hanson and Ballard, 1967). A
discrepancy currently exists over the activity of citrate lyase in dairy cows, particularly
during the peripartum period, with some findings to indicate that citrate lyase activity
increases postpartum in control cows, but remains lower in dairy cows with fatty liver
(Murondoti et al., 2004), with a similar study finding increased citrate lyase levels at 4
wk postpartum, compared to 3 wk prepartum, but a decreased level at 13 wk postpartum
(Graber et al., 2010). In opposition to these findings, no differences were seen in citrate
lyase in dairy cows with high or low BHBA levels during the peripartum period (van
Dorland et al., 2009) or during feed restriction postpartum (Gross et al., 2013). AcetylCoA has also been shown to inhibit citrate lyase, further depressing enzyme activity
(Chesworth and Smith, 1971).
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REGULATION OF PYRUVATE CARBOXYLASE

Pyruvate Carboxylase Gene Promoters
Short-term regulation of PC is largely influenced by availability of the allosteric
activator, acetyl-CoA, as discussed above. Increases in acetyl-CoA supply from the
metabolism of mobilized fatty acids can enhance OAA production by PC and the
cataplerotic supply of carbons to gluconeogenesis. Long-term regulation of PC occurs
through transcriptional regulation of PC gene promoters by both nutritional and
physiological cues. Regulation of PC mRNA expression in mammals is complex. Studies
in rat and mouse models (Jitrapakdee et al., 1996; Jitrapakdee et al., 1997; Jitrapakdee et
al., 2001), and on human PC regulation (Carbone et al., 1998; Thonpho et al., 2013) have
revealed regulation by multiple promoters. Two alternative promoters, the proximal (P1)
and distal (P2), have been identified in rat (Jitrapakdee et al., 1996). Through alternative
splicing, these promoters yield five different mRNA variants, differing only in their 5’
untranslated regions (UTR), produced from different 5’ UTR exons. Illustrating an added
level of genomic complexity, bovine PC gene contains three unique promoter regions
(P3, P2, P1 from 5’ to 3’) which yield six unique 5’ UTR variants (Hazelton et al.,
2008b). Similar to human and rat, tissue-specific PC mRNA expression is seen in bovine
where 5’ UTR A, B, C, and F (arising from promoter 1) are specific to glucogenic and
lipogenic tissues and 5’ UTR D and E (arising from promoter 3 and promoter 2,
respectively) are expressed in several different tissues (Agca et al., 2004; Hazelton et al.,
2008b). In rat, 5’UTR products of P1 are expressed in gluconeogenic and lipogenic
tissues, while 5’UTR products of P2 are more ubiquitous (Jitrapakdee et al., 1996;
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Jitrapakdee et al., 1997). Expression of tissue-specific variants is likely due to the
presence of tissue-specific transcription factors that may interact with specific response
elements of the unique promoters (Jitrapakdee et al., 1999).
Different tissue-specific PC promoters also exhibit different translational
efficiencies. In rats, transcripts from 5’ UTR C or E exhibit similar translational
efficiencies, which are both higher than translational efficiency from 5’ UTR D
(Jitrapakdee et al., 1998). Transcript D was shown to potentially develop a secondary
structure blocking access for translation (Jitrapakdee et al., 1998). Similarly, in bovine,
translation efficiencies of PC mRNA variants A, B, D, and F did not differ (Hazelton et
al., 2008a). Translation efficiency from bovine PC 5’ UTR D was greater than synthesis
from PC 5’ UTR C or E for bovine PC (Hazelton et al., 2008a). The pattern of PC 5’
UTR variants expressed may therefore influence the total rate of PC enzyme synthesis.
Response of species 5’ UTR variants to physiological cues is then of specific interest to
determine the complete pattern of transcriptional regulation of PC. The products of
bovine PC promoter 1, UTR variants A, B, C, and F, exhibit increased expression of 4fold in samples from feed restricted cows and 6-fold during parturition (White et al.,
2011a).

Nutritional Control of Pyruvate Carboxylase
The activity of hepatic PC in rats after a period of starvation dramatically
increases, up to three-fold, compared to activity in control rats (Wimhurst and
Manchester, 1970). This parallel between increased PC activity and decreased caloric
intake is seen in several other species, including bovine (Ballard et al., 1968), guinea pig
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(Söling et al., 1970), and sheep (Taylor et al., 1971; Lemons et al., 1986). Increased
expression of PC mRNA during feed restriction has been reported in mid-lactation dairy
cows (Velez and Donkin, 2005). This increase in PC was concurrent with an increase, of
nearly four times control levels, of lactate converted to glucose (Velez and Donkin,
2005). During this change in the capacity for gluconeogenesis from lactate, plasma
NEFA levels were simultaneously increased in the feed restriction group, compared to
control (Velez and Donkin, 2005). Potential regulation of PC gene expression by fatty
acids is discussed in the following section.
Increased plasma NEFA levels during a period of caloric deprivation result from
the mobilization of adipose tissue reserves. This homeorhetic response to the increased
nutritional demands due to the onset of lactation and demands of the gravid fetus is
heightened during the transition period in dairy cows, the time from 3 wk prior to
parturition until 3 wk after parturition. During this period of dramatic increase in energy
requirement, PC mRNA levels also increase. Hepatic PC mRNA levels are elevated at
calving, and 7 d postpartum (Greenfield et al., 2000). Other gluconeogenic enzymes,
including PCK, do not show this same pattern. Increases in PCK mRNA expression do
not occur until 28 d postpartum (Greenfield et al., 2000; Agca et al 2002).
Dietary fat has been shown to alter whole body metabolism in both rats and mice
(Kraegen et al., 1991; Bizeau et al., 2001; Hagopian et al., 2004). A high saturated fat
diet promotes insulin resistance and obesity with concurrent increases in serum
triglyceride levels in rodents (Kraegen et al., 1991). A study in rats comparing the effects
of high fat, sucrose, or starch in the diet found that increased gluconeogenesis observed in
the high fat and sucrose diets was due to increased flux through PC (Bizeau et al., 2001).
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In dairy cows, diets fed prepartum have been shown to influence the concentration and
profile of circulating fatty acid postpartum (Rukkwamsuk et al., 2000). Taken together
with the concurrent increase in PC postpartum (Greenfield et al., 2000), the role for
potential influence of circulating fatty acids on PC flux becomes of particular interest.

Transcriptional regulation of Pyruvate Carboxylase by long-chain fatty acids
Fatty acids have been shown to alter signal transduction cascades, regulate
activity of G-protein-linked membrane receptors, and, along with their acyl-CoA
derivatives, can bind to several transcription factors, including peroxisome proliferatoractivated receptors (PPAR), sterol regulatory element binding protein (SREBP),
carbohydrate-responsive element-binding protein (ChREBP), liver X receptor (LXR),
farnesoid X receptor (FXR), toll-like receptor 4 (TLR4), hepatic nuclear factor-4 α
(HNF-4α), and nuclear factor (NF) κB, to regulate gene transcription. Circulating long
chain nonesterified fatty acids (NEFA) are transported through blood bound to albumin.
While blood fatty acids also include esterified fatty acids in triglycerides, lipoproteins,
and chylomicrons, these fatty acids, arising from dietary sources, are largely unavailable
to liver as adult liver lacks lipoprotein lipase required to free esterified fatty acids
(Semenkovich et al., 1989; Goldberg et al., 2009). Furthermore, mature ruminant liver
contains essentially no lipoprotein lipase or hepatic triglyceride lipase (Cordle et al.,
1983; Liesman et al., 1984) to allow for lipoprotein utilization. This review will therefore
focus solely on NEFA uptake and utilization.
For cellular uptake, over 90% of cellular long chain fatty acid movement into
cells is through protein-mediated uptake (Kazantzis and Stahl, 2012). Specifically,
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plasma membrane fatty acid-binding protein (FABP), fatty acid translocase (CD36), and
fatty acid transport proteins (FATP), are responsible for the majority of cellular fatty acid
uptake. In addition to their role in cellular fatty acid uptake, it remains unclear if FATP
play a direct role fatty acyl-CoA synthesis or transport within the cell (Jump et al., 2005;
Kazantzis and Stahl, 2012). Inside the cell, fatty acids can serve as signaling molecules
through their influence on cellular receptor systems, including steroid hormones, retinoic
acid, and other hydrophobic molecules (Chawla et al., 2001). Research in several species
has illustrated the role of fatty acids in regulation of PC (Jitrapakdee et al., 2008).
Research on the direct action of fatty acids to control gene expression, especially in
bovine has, thus far, been limited. Responsiveness of other gluconeogenic genes to fatty
acids has been studied in several species, and may provide insight to regulation of PC by
fatty acids and associated intracellular systems in bovine.

Regulation by PPAR
Peroxisome proliferator-activated receptors are nuclear hormone receptors which
function as ligand-dependent transcription receptors, with ligands including small
lipophilic molecules such as fatty acids, peroxisome proliferators, antidiabetic, and
hypolipidemic drugs (Schoonjans et al., 1996). Ligand binding to PPAR elicits
heterodimerization of PPAR with retionoid X receptor (RXR) and subsequent binding to
response elements and recruitment of coactivator proteins. The predominant form in liver
is PPARα, which had been implicated in a central role of lipid metabolism and fatty acid
oxidation (Lee et al., 1995). The PPARα subtype is also expressed in brown adipose
tissue, as well as cardiac and skeletal muscle (Georgiadi and Kersten, 2010). Subtype
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PPARγ is highly expressed in adipocytes and macrophages where it promotes
differentiation of preadipocytes and lipid storage, while subtype PPARδ exhibits a more
ubiquitous expression (Sugden et al., 2010).
Long chain fatty acids, and in particular polyunsaturated fatty acids (PUFA),
preferentially bind to all PPAR subtypes (Krey et al., 1997). The role for PPARα in
mediating hepatic gene expression through unsaturated fatty acids was confirmed from
gene expression profiles in PPARα null mice provided with synthetic dietary triglycerides
comprised of only one fatty acid (Sanderson et al., 2008). Additionally, PPARα null mice
in the fed state exhibit reduced lactate production and gluconeogenesis, while fasted
PPARα null mice are unable to switch to fatty acid oxidation (Xu et al., 2002). Although
PC mRNA expression or enzyme activity was not measured in the PPARα null mice, the
role for PPARα in gluconeogenesis from lactate is clear and may directly relate to PC
activity and potential regulation by fatty acids.
Interestingly, differences are found between the ability of circulating fatty acids,
arising from mobilization of adipose tissue, compared to fatty acids of dietary origin, to
activate PPARα in liver (Chakravarthy et al., 2005; Sanderson et al., 2009). This inability
of circulating fatty acids to activate PPARα may be due to differences in intracellular
pools of fatty acids as only fatty acids of dietary origin acted through PPARα to influence
glucose or fatty acid metabolism in liver-specific fatty acid synthase knockout mice
(Chakravarthy et al., 2005). Differences are also seen in PPARα activation in response to
physiological cues during fasting compared to response to pharmacological agonists
where PPARδ is responsive to circulating fatty acids, but the same is not true for PPARα
in mouse liver (Sanderson et al., 2009). This difference in response to fatty acids of
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dietary or adipose origin may be of particular interest in the periparturient dairy cow
when feed intake electively decreases and adipose tissue mobilization increases.
However, implications from these studies must carefully be considered because of the
lack of lipoprotein lipase or hepatic triglyceride lipase in ruminant liver (Cordle et al.,
1983; Liesman et al., 1984) which limits utilization, by liver, of fatty acids from
chylomicrons of dietary origin. Studies evaluating the response of different PPAR
isoforms to fatty acids of either dietary or adipose origin in ruminants are lacking, but
lipoprotein lipase is shown to be increased by PPARα ligands in human macrophages (Li
et al., 2002).
Direct regulation of genes involved in fatty acid metabolism through PPARα has
been examined in both rodent and bovine. Research in rodent models had indicated that
the proximal PC promoter is responsive to PPARα activation (Jitrapakdee et al., 2008).
Increased PC expression is seen in isolations of pancreatic islets from rats after treatment
with either long chain fatty acids or synthetic PPARα agonist, fibrate, concurrent with an
increase in PPARα expression (Yoshikawa et al., 2001). In bovine, responsiveness of
carnitine palmitoyltransferase (CPT) I activity is seen in Madin-Darby bovine kidney
(MDBK) cells after exposure to the PPARα agonist Wy-14643 (Bionaz et al., 2008a),
while direct activation of PPARα by long chain fatty acid is seen in the same cell model
(Thering et al., 2009). Specific regulation of bovine PC promoter 1 is seen with activation
by PPARα and a decrease in promoter activity after exposure to saturated fatty acids
(White et al., 2011c). Finally, both PPARα and PPARδ have been shown to increase lipid
oxidation in heart, intestine, kidney, and liver (Sugden et al., 2010; Jump et al., 2013). In
neonatal bovine hepatocyte isolations, exposure to a PPARα agonist increased oxidation
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of C16:0 to CO2, compared to control (Litherland et al., 2010). The importance of fatty
acid oxidation in relation to the role of PC is discussed below. Together, these data lend
support to the hypothesis than fatty acid influence on PC mRNA expression is mediated
through PPARα.

Regulation by SREBP
Sterol regulatory element binding proteins are members of the basic helix-loophelix leucine zipper family of transcription factors and exhibit three isoforms, SREBP-1a,
SREBP-1c and SREBP-2, from two separate genes. The isoforms are expressed in a
tissue-specific manner and elicit their effects on different target genes with SREBP-1c
activating genes for de novo lipogenesis and SREBP-2 activating genes involved in the
synthesis and uptake of cholesterol (Georgiadi and Kersten, 2010). Synthesized as
membrane-bound precursors in the endoplasmic reticulum, activation of SREBP requires
cleavage by cholesterol-sensing proteins, known as SREBP cleavage activating proteins
(SCAP). Cleavage and release of SREBP allows for nuclear translocation and binding to
response elements (Hua et al., 1995). Serving, in effect, as cholesterol-sensing proteins,
SCAP promote cleavage and SREBP nuclear translocation when cholesterol levels are
low. Increased cellular cholesterol concentrations leave the SREBP-SCAP complex
sequestered by endoplasmic reticulum (ER) membrane proteins (Hua et al., 1995).
All SREBP isoforms are inhibited by PUFA, as these fatty acids act to both
decrease SREBP mRNA levels, and prevent the cleavage and processing required for
SREBP maturation (Xu et al., 1999). Inhibition of SREBP through PUFA has recently
been attributed to the inhibition of Ubxd8, a membrane-bound protein responsible for
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degrading the proteins anchoring the SREBP-SCAP complex to the ER (Lee et al., 2010).
Inhibition of Ubxd8 and the related anchoring protein leaves the SREBP-SCAP
inactivated and stranded in the ER.
The predominant isoform in liver, SREBP-1c, plays a direct role in the regulation
of lipogenesis and is responsible for the activation of fatty acid and triglyceride synthesisrelated gene transcription (Shimano, 2009). Expression of SREBP-1c is increased during
periods of elevated glucose concentrations and during over-nutrition, and is upregulated
by insulin and agonists of LXR. Long-term elevation of SREBP-1c can induce insulin
resistance and fatty liver (Horton et al., 1998; Nakamura et al., 2004). In opposition,
SREBP-1c is downregulated by PUFA (Shimano, 2009). Recent research has established
a relationship between elevated C18:0 levels in Type II diabetes patients with
hyperlipidemia from increased fatty acid synthesis due to signaling through SREBP-1c
(Chu et al., 2013). Any potential relationship between SREBP signaling and PC
expression has not been examined in ruminants or nonruminants.

Regulation by LXR and Relationship to SREBP
Liver X receptors belong to the nuclear receptor superfamily, are responsive to
sterols, and are relevant to several metabolic systems, including growth and development,
reproduction, overall metabolism, and, specifically, Type II diabetes (Ding et al., 2014).
The LXR are activated by oxysterols, derivatives of cholesterol, and activate genes for
cholesterol and bile excretion (Nakamura et al., 2014). Liver X receptor null mice exhibit
aberrant cholesterol accumulation and liver metabolism (Peet et al., 1998). Effects of
LXR on other metabolic aspects occur through interactions with either SREBP-1c or
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PPARα. Two functional LXR response elements are found in the promoter region of the
SREBP-1c gene (Repa et al., 2000). Through activation of SREBP-1c, LXR also induces
genes for de novo lipogenesis (Nakamura et al., 2014). Evaluation of cross-talk between
PPARα and LXR demonstrated that overexpression of PPARα in human embryonic
kidney cells inhibited LXR-induced SREBP-1c activity (Yoshikawa et al., 2003).
Confirmed through gel shift assays and incubation with PPARα agonists, the activation of
PPARα is likely competitively reducing formation of a LXR-RXR heterodimer to reduce
signaling through the LXR-SREBP-1c pathway (Yoshikawa et al., 2003).

Regulation by TLR4
Toll-like receptors are highly conserved proteins intricately involved in the innate
immune response which recognize pathogen-associated molecular patterns and mediate
cytokine responses (Galli and Calder, 2009). Effects of fatty acids on inflammatory
response have been extensively studied and data largely support a proinflammatory role
of saturated fatty acids and an anti-inflammatory role of n-3 PUFA (Galli and Calder,
2009). While much of the influence from fatty acid metabolism is likely from
metabolites, including prostaglandins, leukotrienes, and diacylglycerols, a direct role also
exists for fatty acids in both pro- and anti-inflammatory pathways. The TLR4 subtype is
of particular interest because of the activation of the receptor by both lipopolysaccharides
and fatty acids. In both adipocytes and monocytes, saturated C16:0 and C18:0 serve as
direct ligands to stimulate TLR4 signaling and elicit downstream NFκB activation and
proinflammatory cytokine release (Kopp et al., 2009; Schaeffler et al., 2009).
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Taken together, previous research strongly suggests a role of both unsaturated and
saturated fatty acids, through their influence on PPARα and SREBP-1c, respectively, in
regulating hepatic gene expression. Presently, the role of these lipid classes as regulators
of hepatic gene expression in bovine, and transition dairy cows in particular, is unknown.
Data for PC regulation in nonruminants and emerging data for ruminants suggests
dominant regulation by unsaturated fatty acid on potential PPARα response elements of
PC. A role of LXR as a cotranscription factor is also plausible when considering the
established role of cross-talk between PPARα, LXR, and SREBP-1c. Research is lacking
that links these pathways to regulation of metabolically controlled genes, such as PC, in
cattle.

FATTY ACID METABOLISM AND β-OXIDATION

Long-chain fatty acids are mobilized from adipose tissue during increased energy
requirements, which exceed energy supply, in the form of NEFA that bind to serum
albumin and are transported in blood (Dole, 1956; Gordon and Cherkes, 1956). In dairy
cows, circulating NEFA taken up by liver in proportion to their concentration in blood
(Emery et al., 1992) and are subject to one of several metabolic fates, including complete
oxidation to CO2 or partial oxidation to yield ketone bodies (reviewed in full below).
Because PC is allosterically regulated by acetyl-CoA, and because the anaplerotic
potential of PC depends on acetyl-CoA condensing with OAA to enter the TCA cycle,
supply of acetyl-CoA from fatty acid β-oxidation is of particular interest.
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Fatty acid β-oxidation pathway
The catabolic breakdown of fatty acids in mitochondria yields acetyl-CoA, which
can enter the TCA cycle, and NADH and FADH2, which are used in the electron
transport chain (Berg et al., 2002). In healthy individuals, decreases in circulating glucose
and insulin levels during fasting permit the activation of adipose tissue hormone-sensitive
lipase (HSL) by opposing endocrine signals to increase NEFA mobilization (Bennett,
2010). Activation of HSL in adipose tissue occurs through the protein kinase A cascade
promoting HSL to translocate and hydrolyze triglycerides from lipid droplets. In contrast
to nonruminants, adipose triglyceride lipase is decreased during the periparturient period
in dairy cows (Koltes and Spurlock, 2011). Fatty acids are oxidized in mitochondria but
must first be activated, at the outer mitochondrial membrane, by acyl-CoA synthetase /
fatty acid thiokinase to long chain fatty acyl-CoA. Activated long chain fatty acyl-CoA
are then conjugated to carnitine for transport across the mitochondrial membrane,
facilitated by the outer-membrane-bound CPT I (Berg et al., 2002). Four enzymecatalyzed reactions are then required for fatty acid β-oxidation: dehydrogenation by acylCoA dehydrogenase, hydration by enoyl-CoA hydratase, dehydrogenation by 3-Lhydroxyacyl-CoA dehydrogenase, and cleavage by thiolase. The resulting fatty acyl-CoA
is shortened by two carbons while acetyl-CoA, NADH and FADH2 are generated (Berg et
al., 2002). Resulting acetyl-CoA can then continue to complete oxidation through the
TCA cycle (pathway discussed above) only if fat and carbohydrate metabolism are
balanced. If OAA is unavailable for condensation with acetyl-CoA, acetyl-CoA is then
diverted to ketone body formation (Berg et al., 2002).

28
Fatty Acyl-CoA
FAD
Acyl-CoA dehydrogenase
FADH2
Trans-2-Enoyl-CoA
H2O
Enoyl-CoA hydratase

3-Hydroxyacyl-CoA
NAD+
3-L-Hydroxyacyl-CoA dehydrogenase
NADH + H+
β-Ketoacyl-CoA
CoASH
β-Ketoacyl-CoA thiolase
Acetyl-CoA
Fatty Acyl-CoA; 2 carbon atoms shorter

Figure 1.2. Fatty acid β-oxidation; substrates, products, and associated enzymes.
Activated fatty acyl-CoA are conjugated to carnitine for transport across the
mitochondrial membrane, facilitated by carnitine palmitoyltransferase (CPT) I, prior to βoxidation. Acetyl-CoA resulting from the final cleavage step can be oxidized through the
tricarboxylic acid (TCA) cycle to yield ATP and CO2.
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Role of fatty acid β-oxidation in liver and kidney tissue
Complete oxidation of fatty acids to CO2 necessitates a balance between
mitochondrial β-oxidation and peroxisomal β-oxidation. Peroxisomal β-oxidation is
utilized for breakdown of fatty acids longer than 20 carbons before further oxidation in
the mitochondria proceeds (Osmundsen et al., 1991). While mitochondrial β-oxidation is,
in large part, dependent upon CPT I activity (McGarry and Brown, 1997), limitations in
CPT I activity have not been linked to propensity for metabolic disorders in periparturient
dairy cows (Dann and Drackley, 2005).
Kidney and liver are the only tissues in which both mitochondrial β-oxidation and
peroxisomal β-oxidation of fatty acids can occur (Osmundsen et al., 1991; Zaar, 1992).
Complete oxidation of long chain fatty acids, specifically C16:0, to CO2 by extrahepatic
tissues was first demonstrated in vitro in murine kidney slices (Weinhouse et al., 1950).
Oxidation of C16:0 to CO2 in kidney slices or homogenates was equal to or greater than
oxidation of C16:0 to CO2 in liver slices or homogenates (Weinhouse et al., 1950). Early
liver explant incubations in bovine illustrated that oxidation of C16:0 is stimulated by
carnitine and inhibited by propionate (Jesse et al., 1986). In liver of dairy cows,
peroxisomal β-oxidation contributes 50% of first cycle total C16:0 β-oxidation (Grum et
al., 1994). Importance of the capacity for oxidation in dairy cows is emphasized around
parturition and was previously shown to increase in the oxidation of C16:0 in liver tissue
slices (Grum et al., 1996). In a rodent model, regulation of fatty acid oxidation is
demonstrated after dietary fat containing high amounts of C18:3n-3 cis increase both
mitochondrial and peroxisomal fatty acid β-oxidation in rat liver (Ide et al., 1996).
Experiments performed in bovine hepatocytes examined the influence of fatty acids after
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48 h exposure and found a decrease in fatty acid esterification to triglycerides when
C18:3n-3 cis was included in treatment media (Mashek and Grummer, 2003). An
increase in gluconeogenesis is also seen after exposure to C18:3n-3 cis in hepatocytes
(Mashek and Grummer, 2003). The negative effects of overfeeding during the dry period
on enzymes related to NEFA oxidation in liver have also been established (Murondoti et
al., 2004), while lower rates of C16:0 oxidation to CO2 are observed after overfeeding
during the far-off dry period with a concurrent increase in the esterification of
triglycerides (Litherland et al., 2011). These studies effectively established a method for
analysis of fatty acid substrate metabolism, and illustrated influences of diet and,
specifically, fatty acids, but did not measure PC mRNA expression or enzyme activity,
and the exact role of PC remains uncertain.
Fatty acid β-oxidation also occurs in proximal kidney tubules of the renal cortex
and is increased during diabetes (Guder et al., 1986). Potentially strengthening the link
between fatty acid β-oxidation and PC activity, fatty acids that are increased in
circulating concentrations during diabetes are found to induce expression of several fatty
acid β-oxidation enzymes and promote the utilization of fatty acids (Ouali et al., 1998).
Furthermore, all PPAR isoforms are detected in kidney cortex (Wang, 2010). As bovine
PC promoter 1 activated by PPARα agonist (White et al., 2011c), the relevance of
examining kidney metabolism in the current research holds true.
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ROLE OF PYRUVATE CARBOXYLASE IN ABERRANT METABOLISM

Evolutionary conservation and biological importance
The PC gene has been highly conserved through evolution and is found in both
bacteria and eukaryotic cells. Well characterized in Saccharomyces cerevisiae, this yeast
contains two functional PC gene copies; PYC1 and PYC2, with both isozymes being
located in the cytoplasm (Walker et al., 1991). This is in contrast to cellular localization
of PC in the mitochondrial matrix, near the mitochondrial inner membrane, in higher
eukaryotes (Rhode et al., 1991). A single PC gene is found in rats, humans, and cows
with high similarity; containing 19 coding exon regions and 18 introns (Jitrapakdee and
Wallace, 1999; Hazelton et al., 2008b). Mammalian control of PC expression is
intricately regulated by distinct promoters, discussed in full detail in previous sections.
The pivotal role of PC in several physiological states will be the focus of the following
section. The biological importance of the enzymes is perhaps most easily illustrated by a
brief review of studies of compromised PC function.
Generation of PC-deficient mutants in S. cerevisiae result in altered phenotypes,
while defects in either the PC1 or PC2 genes led to growth failure in yeast on glucose
media (Walker et al., 1991; Brewster et al., 1994). Deficiency of PC in humans is an
autosomal, recessive trait, which manifests as one of three, nearly distinct, phenotypes
(Gray et al., 2014). Type A PC deficiency, found in North American populations, is
characterized by decreased, though not abolished, PC activity, episodic lactic acidosis,
elevated alanine and proline levels, hypoglycemia, and developmental delays (Robinson,
2006). Decreases in both gluconeogenesis and activity of the TCA cycle are responsible
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for decreased OAA and glucose, and increased alanine, lactate, and pyruvate in these PCdeficient individuals (Jitrapakdee and Wallace, 1999). Life expectancy of Type Adeficiency patients is usually several years (Gray et al., 2014). In contrast, Type B PC
deficiency, historically reported in French populations, is characterized by near absence
of PC protein or enzyme activity. Severe lactic acidosis and neurological deficits occur,
and lifespan in these patients is usually only several months (Robinson, 2006). Type C
PC deficiency is, in comparison, a very mild form of the disease, lacking neurological
complications and exhibiting limited and infrequent lactic acidosis (Gray et al., 2014).
Point mutations leading to altered protein stability or lower enzyme activity have been
identified in patients with Type A PC deficiency, and PC activity among these patients is
around 50% (Wexler et al., 1998). The genotype for Type B deficiency has not yet been
identified. The severe implications of PC deficiency emphasize the central role for the
enzyme in numerous metabolic pathways.

Obesity and Type II Diabetes Mellitus
Type II diabetes mellitus, or noninsulin-dependent diabetes mellitus, is a
metabolic disorder arising from both genetic and lifestyle factors characterized by
hyperglycemia, insulin resistance, and insulin deficiency. Increases in all gluconeogenic
genes; PC, PCK, fructose-1,6-bisphosphatase, and glucose-6-phosphatase have been
reported during diabetes mellitus (Filsell et al., 1969; Wimhurst and Manchester, 1970;
Weinberg and Utter, 1980). Insulin has been previously shown to decrease this elevated
PC expression, by two-fold, in diabetic rats (Weinberg and Utter, 1980). Genetically
obese rats also exhibit dramatic increases in PC expression, which has been specifically
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attributed to a response by the distal PC promoter in pancreatic β-cells (Jitrapakdee et al.,
1998). Increased gluconeogenesis in diabetes was later specifically attributed to an
increase in flux through PC in its cataplerotic role in both mice and rats (Salto et al.,
1996).
In a genetically inherited Type II diabetic rat model, elevated glucose levels due
to insulin resistance results in a “glucotoxicity loop” and concomitant decrease in PC
activity (MacDonald et al., 1996a,b; Poitout et al., 2002). The ensuing “lipotoxicity loop”
only serves to increase insulin resistance, decrease PC activity, and decrease pancreatic βcell function (Poitout et al., 2002). Finally, identification of a single nucleotide
polymorphism in the PC gene has been identified and linked to the acute insulin response
phenotype, an independent predictor of Type II diabetes mellitus (Palmer et al., 2006).

Ketosis and Fatty liver
Hepatic steatosis, or the accumulation of excessive lipid in liver, has been linked
to the development of nonalcoholic fatty liver disease (Malhi and Gores, 2008).
Accumulation of these liver lipids occurs from an imbalance between the rates of
synthesis and disposal. How liver responds to the excess lipid load during the increased
influx determines potential susceptibility to development of hepatic steatosis.
The 6 wk period surrounding parturition in dairy cows is aptly referred to as the
transition period. As this moniker implies, drastic metabolic changes are occurring as a
homeorhetic response to increased nutrient needs of the fetus, and the onset of
lactogenesis. During this period of extreme negative energy balance, adipose tissue
reserves are mobilized, releasing NEFA into the bloodstream which are transported to
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liver for mitochondrial metabolism (Baird et al., 1968; LeBlanc, 2010). Concurrent with
increased circulating NEFA from adipose tissue triglyceride lipolysis, the rate of blood
flow increases during the periparturient period in dairy cows (Lomax and Baird, 1983).
Circulating NEFA in dairy cows are taken up by liver proportional to their concentration
in blood (Emery et al., 1992) and are subject to one of four possible fates: complete
oxidation through the tricarboxylic acid (TCA) cycle yielding ATP and CO2, partial
oxidation yielding ketone bodies, esterification for storage in liver as triglycerides, or
transport from the liver as very low density lipoprotein (VLDL) for use by extrahepatic
tissues (reviewed by Grummer, 1993; Drackley et al., 2001; Bobe et al., 2004; van
Knegsel et al., 2005). With the cost of hepatic steatosis to the United States dairy industry
estimated at US$60 million annually and the prevalence of hepatic steatosis in early
lactation dairy cows at over 50% (Bobe et al., 2004), potential strategies to mitigate the
severity of the disease and the cost to dairy producers are necessary.
Dairy cows exhibit an inherently low capacity for export of VLDL from liver, and
display an upper limit of extrahepatic tissues to utilize ketone bodies (Kleppe et al., 1988;
Armentano et al., 1991; Emmison et al., 1991). This is, in part, due to the fact that
ruminants express limited concentrations of the proteins necessary for VLDL packaging,
including apolipoprotein B and apolipoprotein A-I (Grummer, 1993, Bobe et al., 2004).
This puts a dairy cow at an even greater risk for developing ketosis or fatty liver.
Decreases in feed intake during the transition period may result in decreased carbon
supply from propionate and decreased availability of OAA to serve as a substrate (van
Knegsel et al., 2005). Increased production of acetyl-CoA, resulting from fatty acid βoxidation, during a period of increased energy demand could surpass the capacity of the
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TCA cycle for complete oxidation. If OAA and acetyl-CoA are not present in an equal
ratio to serve as TCA cycle substrates, other metabolic fates of acetyl-CoA will
predominate. Increased rates of ketogenesis to acetate and acetoacetate from acetyl-CoA,
along with increased esterification to storage triglycerides (Grummer 1993, Drackley et
al., 2001, van Knegsel et al., 2005) would simply exacerbate the delicate metabolic
situation of the transition cow. While the decrease in feed intake is usually greater in
obese cows compared to healthy individuals (Stockdale, 2001), NEFA mobilization in
obese dairy cows is also more severe (McNamara, 2000). Because liver lipids can
accumulate very rapidly and fatty liver can develop in as little as 96 h in dairy cows
(Grummer et al., 1990), the risk to development of metabolic disease is clear.
Additionally, postpartum concentration of C16:0, C18:0, and C18:1n-9 cis were
significantly increased in lactating dairy cows with fatty liver, compared to levels in
control cows (Rukkwamsuk et al., 2000), indicating a potential detrimental effect of these
particular fatty acids in whole body metabolism.
Recent research has extensively examined the response of PC promoter to fatty
acids and PPARα agonist (White et al., 2011b.c), but it remains unclear the dominance of
control of specific fatty acids on PC mRNA expression or promoter activity, and if
changes in PC will indeed correlate to changes in oxidative pathway flux or the capacity
of the TCA cycle.
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CONCLUSIONS AND FUTURE DIRECTIONS

The central role that PC plays in several biosynthetic pathways is clear. Pyruvate
carboxylase is responsible for the conversion of pyruvate to OAA, with the cellular fate
of OAA determined by the energy status of the cell. Pyruvate carboxylase expression is
tissue-specific due to regulation by, in bovine, three separate promoters that give rise to
six unique 5’ UTR variants. The response of PC to physiological stressors, including and
elevated circulating fatty acid profile, is of utmost importance to dairy cows during the
period of negative energy balance surrounding the transition period.
The guiding hypothesis for this dissertation is that the circulating fatty acid
profile, and specifically the ratio of saturated to unsaturated fatty acids, influences the
capacity for cellular oxidation and the production of OAA, through specific influences on
PC and PC promoter 1. These data are needed to provide valuable insight into the control
of PC and fatty acid metabolism. If the intricate balance present between the anaplerotic
and cataplerotic roles of PC and OAA may be manipulated through plasma fatty acid
profiles to either prevent, or better respond to, metabolic stressors inherent to the
periparturient period in dairy cows.
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CHAPTER 2. FATTY ACID CHAIN LENGTH AND DEGREE OF
SATURATION REGULATE EXPRESSION OF PYRUVATE
CARBOXYLASE MESSENGER RNA IN MADIN-DARBY BOVINE KIDNEY
CELLS AND BOVINE PRIMARY HEPATOCYTES

ABSTRACT

Pyruvate carboxylase (PC) catalyzes oxaloacetate (OAA) synthesis and links
gluconeogenesis and the anaplerotic generation of OAA. Previous work links bovine PC
mRNA expression to nonesterified fatty acids (NEFA). Our objective was to determine
effects of chain length and degree of saturation through copresence of saturated and
unsaturated fatty acids on PC mRNA. For Experiment 1, Madin-Darby bovine kidney
(MDBK) cells were grown to 80% confluence and exposed for 24 h to either individual
fatty acids bound to BSA (C16:0, C18:0, C18:1n-9 cis or C18:3n-3 cis) or their
combinations at increasing molar ratios for C16:0: C18:3n-3 cis or C18:0: C18:3n-3 cis
or C18:1n-9 cis: C18:3n-3 cis. For Experiment 2, 20 h after seeding, isolated bovine
hepatocytes were similarly exposed for 24 h to individual fatty acids (C16:0, C18:0, or
C18:3n-3 cis) or their combinations at increasing molar ratios for C16:0: C18:3n-3 cis or
C18:0: C18:3n-3 cis. Total fatty acid concentration was 1.00 mM for all incubations.
Both C16:0 and C18:0 independently decreased (P < 0.05) PC mRNA relative to control
(0.48, 0.16, and 2.33 ± 0.48 for C16:0, C18:0, and control, respectively) in MDBK cells.
The ratio of 75:25 C18:0: C18:3n-3 cis increased PC expression compared to C18:0
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treatment alone (1.97 vs. 0.16 ± 0.34, for 75:25 C18:0: C18:3n-3 cis, and C18:0,
respectively; P < 0.05) in MDBK cells. The ratio of 75:25 C16:0: C18:3n-3 cis
significantly increased PC mRNA expression compared with C16:0 alone, but only 50:50
C16:0: C18:3n-3 cis could recover PC expression to levels similar to control (1.41, 0.48,
2.08, and 2.33 ± 0.48 for 75:25 C16:0: C18:3n-3 cis, C16:0, 50:50 C16:0: C18:3n-3 cis,
and control, respectively; P < 0.05) in MDBK cells. For primary bovine hepatocyte,
exposure to C18:3n-3 cis significantly elevated (P < 0.05) PC mRNA expression relative
to control, C16:0 or C18:0. There was no effect of C16:0, C18:0 or combinations of
C16:0 or C18:0 with C18:3n-3 cis. Results indicate that C18:3n-3 cis is a more potent
alleviator of PC depression in C18:0 treated MDBK cells compared to C16:0: C18:3n-3
cis treatments. C18:1n-9 cis treatments did not depress PC (P > 0.10) in MDBK cells,
revealing fatty acid saturation is key in PC expression. PC activation by unsaturated fatty
acids may play a critical role in setting the capacity for OAA synthesis.

Keywords: bovine, fatty acid, pyruvate carboxylase
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INTRODUCTION

Accumulation of liver lipids, known as hepatic steatosis, is a predisposing
condition to nonalcoholic fatty liver disease and occurs from an imbalance in lipid
synthesis and disposal (Malhi and Gores, 2008). The capacity of liver to metabolize fatty
acids released from adipose tissue determines, at least in part, susceptibility to hepatic
steatosis. Likewise, both the type and amount of dietary fatty acids have been shown to
influence whole-body metabolism, as well as hepatic gene expression (Ooi et al., 2013).
In rodents, diets high in saturated fat increase serum triglyceride levels and promote the
development of obesity and insulin resistance (Kraegen et al., 1991). Previous studies
show that regulation of gene expression by circulating fatty acids occurs either through
indirect mechanisms to alter cellular metabolism or directly by acting to regulate
transcription factor activity (Jump et al., 2013). Therefore, circulating fatty acids may
influence susceptibility to metabolic diseases by altering responsiveness to endocrine and
metabolic signals.
During the transition to lactation, the 6 wk period surrounding parturition, a dairy
cow experiences a period of negative energy balance when adipose tissues are mobilized
and fatty acids are released into blood and transported to liver for metabolism (LeBlanc,
2010). In dairy cows, circulating fatty acids are taken up by liver in proportion to their
concentration in blood (Emery et al., 1992). In liver, fatty acids are metabolized and have
one of four possible fates: complete oxidation through the tricarboxylic acid (TCA) cycle
yielding ATP and CO2, incomplete oxidation yielding ketone bodies, transport from the
liver as very low density lipoprotein (VLDL), or esterification for storage in liver as
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triglycerides (reviewed by Grummer, 1993; Drackley et al., 2001; Bobe et al., 2004; van
Knegsel et al., 2005). Because the prevalence of hepatic steatosis is over 50% in dairy
cows with a cost to the United States dairy industry of approximately US$60 million
annually (Bobe et al., 2004), strategies are sought to reduce the incidence and severity of
the disease. With the inherently low capacity of ruminant liver to export VLDL (Kleppe
et al., 1988; Armentano et al., 1991; Emmison et al., 1991,), as well as a maximum level
for use of ketone bodies by extrahepatic tissues, a promising avenue to reduce the
incidence of hepatic steatosis in dairy cows may be to promote alternative metabolism of
fatty acids through oxidation to CO2.
Pyruvate carboxylase (PC; EC 6.4.1.1) catalyzes oxaloacetate (OAA) synthesis
and ostensibly links the cataplerotic pull of carbons away from the tricarboxylic acid
cycle (TCA), specifically through gluconeogenesis, and the anaplerotic generation of
OAA. Expansion of the OAA pool can increase the potential capacity of the TCA cycle
and promote an increase in complete oxidation of acetyl-CoA as long as the activities of
cytosolic phosphoenolpyruvate carboxykinase (PCK1) and mitochondrial
phosphoenolpyruvate carboxykinase (PCK2) are not increased (Jitrapakdee et al., 2006).
A reduction in PC activity has long been associated with a decrease in the pool of OAA
in mitochondria of glucogenic tissues during increased gluconeogenesis in ketotic cows
(Baird et al., 1968).
Pyruvate carboxylase mRNA expression is significantly increased around the time
of calving and during feed restriction in dairy cows while other enzymes related to
glucose production are not affected (Greenfield et al., 2000; Velez and Donkin, 2005).
Changes in the profile of circulating fatty acids around parturition may influence
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gluconeogenic enzymes, including PC. Fatty acids have previously been shown to
regulate PC gene expression in several species (Jitrapakdee et al., 2008). Previous work
also demonstrates activation of bovine PC mRNA in response to a peroxisome
proliferator-activated receptor-α (PPARα) agonist but a decrease with exposure to
saturated fatty acids (White et al., 2011b).
Diets fed to dairy cows during the dry period have been shown to alter circulating
fatty acid profiles and concentrations at calving (Rukkwamsuk et al., 2000). Dairy cows
with induced fatty liver postpartum had significantly greater concentrations of serum
C16:0, C18:0, and C18:1n-9 cis relative to fatty acid serum concentrations from control
cows (Rukkwamsuk et al., 2000). Furthermore, feeding diets rich in flaxseed, a source of
C18:3n-3 cis, starting from 6 wk before calving significantly decreased the accumulation
of liver triglycerides after calving compared to control cows or those receiving saturated
fat supplements during the dry period (Petit et al., 2007), suggesting that inclusion of
dietary C18:3n-3 cis alters hepatic fatty acid metabolism. Long chain fatty acids have
also been shown to regulate fatty acid oxidation in rodents (Ide et al., 1996) and dietary
fat containing high amounts of C18:3n-3 cis increased both mitochondrial and
peroxisomal oxidation rates, as well as increased activities of enzymes related to βoxidation in rat liver.
We hypothesized that bovine PC mRNA expression is differentially regulated by
saturated and unsaturated fatty acids and the balance of fatty acids determines PC mRNA
abundance. Our objective was to determine the effects of fatty acid chain length, degree
of saturation, and copresence of saturated and unsaturated fatty acids on PC mRNA
expression. We first utilized Madin-Darby bovine kidney (MDBK) cells as a model
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system for these experiments as enzymes associated with glucogenic pathways have
previously been studied in MDBK cells (Bionaz et al., 2008a,b; Thering et al., 2009;
White et al., 2012). Additionally, this cell line permits prolonged exposure to fatty acids
and other factors. A parallel experiment was completed in isolated bovine hepatocytes to
examine the effects of fatty acids on PC mRNA expression in bovine liver.

MATERIALS AND METHODS

Experiment 1
Cell Culture. Madin-Darby bovine kidney epithelial cells (NBL-1 ATCC CCL22) were obtained at passage 110 from the American Type Culture Collection (ATCC,
Manassas, VA). Cells were propagated in sterile polystyrene 150-cm2 canted-neck, 0.2
µm vent cap flasks (Corning, Corning, NY) in Dulbecco’s Modified Eagle’s Medium
(DMEM) containing 1 g/L D-glucose, L-glutamine, and 110 mg/L sodium pyruvate (Life
Technologies, Grand Island, NY) supplemented with 10% fetal bovine serum (FBS;
Sigma-Aldrich Corp., St. Louis, MO), 100 units/mL penicillin, 100 µg/mL streptomycin,
and 250 ng/mL amphotericin B (Antibiotic-Antimycotic Solution; Sigma-Aldrich Corp.,
St. Louis, MO) at 37°C in 5% CO2 and 95% air. Media was refreshed every two to three
d. Cells were subcultured to near confluence following media removal with trypsinEDTA (Sigma-Aldrich Corp., St. Louis, MO). Trypsin activity was inhibited by addition
of 10 mL of fresh DMEM supplemented with 10% FBS (Sigma-Aldrich Corp.), 100
units/mL penicillin, 100 µg/mL streptomycin, and 250 ng/mL amphotericin B
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(Antibiotic-Antimycotic Solution; Sigma-Aldrich Corp.). For each experimental
replicate, cells were plated on 6-well plates (Corning, Glendale, AZ) at a density of 5 ×
105 cells per 35-mm diameter well and incubated in 10% FBS DMEM with antibiotics, as
indicated above, to achieve approximately 80% confluence before exposure to treatments.
Fatty acid treatments. Fatty acids C16:0, C18:0, C18:1n-9 cis, C18:3n-3 cis
(Sigma-Aldrich Corp.) were bound to BSA (Probumin; Millipore, Billerica, MA) in a 4:1
molar ratio as described previously (Berry et al., 1991). MDBK cells at 80% confluence
were cultured in DMEM and exposed for 24 h to either 1% BSA (no addition control), or
to 1.0 mM individual fatty acid (bound to BSA), or to combinations of fatty acids in
10:90, 25:75, 50:50, or 75:25 molar ratios from combinations of C16:0: C18:3n-3 cis, and
in 25:75, 50:50, 75:25, or 90:10 molar ratios from combinations of C18:0: C18:3n-3 cis,
or C18:1n-9 cis: C18:3n-3 cis. Total fatty acid concentration in each combination was 1.0
mM and total BSA concentration was 1%. Treatments were applied in triplicate to three
separate MDBK cell replicates.

Experiment 2
Care and Use of Hepatocyte Donor Animals. All experimental procedures
involving animals were approved by the Purdue University Animal Care and Use
Committee. Intact male dairy calves were fed colostrum at birth followed by milk diet at
10% of birthweight and delivered as two equal portions twice daily. Animals were
selected as hepatocyte donors within 7 d of age, were given heparin (1, 000 USP, Sagent
Pharmaceuticals, Schaumburg, IL) intravenously and anesthetized with 1% propofol (6
mg/kg calf body weight, Hospira Inc. Lake Forest, IL) via intravenous injection. The
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caudate process was excised and the animals were euthanized immediately by
intravenous injection of saturated potassium chloride (150 mg/kg calf body weight;
Sigma-Aldrich Corp., St. Louis, MO).
Hepatocyte Monolayer Preparation and Culture. Liver cells were dispersed via
collagenase perfusion as described previously (Donkin and Armentano, 1993). The
isolated hepatocytes were plated onto 35-mm Falcon Primaria Easy Grip tissue culture
dish (Becton Dickinson, Lincoln Park, NJ) at an approximate density of 5.3 x 104
cells/cm2 in DMEM containing 20% FBS and 100 units/mL penicillin, 100 µg/mL
streptomycin, and 250 ng/mL amphotericin B (Antibiotic-Antimycotic Solution; SigmaAldrich Corp., St. Louis, MO). After 4 h, the plating media and unattached cells were
removed by aspiration and media was replaced with DMEM containing 10% FBS and
1% antibiotic, antimycotic solution. Twenty hours after seeding plates, media was
removed by aspiration and replaced with DMEM containing 1% BSA and the fatty acid
treatments described below.
Fatty acid treatments. Fatty acids C16:0, C18:0, C18:3n-3 cis (Sigma-Aldrich
Corp.) were bound to BSA (Probumin; Millipore, Billerica, MA) in a 4:1 molar ratio as
described previously (Berry et al., 1991). Twenty hours after seeding, hepatocytes were
cultured in DMEM and exposed for 24 h to either 1% BSA (no addition control), or to
1.0 mM individual fatty acid (bound to BSA), or to combinations of fatty acids in 10:90,
25:75, 50:50, or 75:25 molar ratios from combinations of C16:0: C18:3n-3 cis, and in
25:75, 50:50, 75:25, or 90:10 molar ratios from combinations of C18:0: C18:3n-3 cis.
Total fatty acid concentration in each combination was 1.0 mM and total BSA
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concentration was 1%. Treatments were applied in triplicate to five separate hepatocyte
isolations.

Cell Sample Collection, RNA Isolation, and Transcript Quantification
Samples from both Experiment 1 and Experiment 2 were processed identically.
After exposure to treatments for 24 h, media was removed and cells were disrupted and
lysed by adding 350 µL Buffer RLT (RNeasy Mini Kit, Qiagen Inc., Germantown, MD).
Plates were shaken on an orbital shaker (Barnstead International, Dubuque, IA) for 10
minutes and cell lysates collected to a 1.5 mL microcentrifuge tube. Lysates were stored
at -80°C until subsequent RNA isolation.
Cell lysates were homogenized by vortexing and processed using the RNeasy
Mini Kit according to manufacturer directions (Qiagen Inc., Germantown, MD). Purified
RNA was quantified for each sample by absorbance at 260 nm using a ND-1000
spectrophotometer (NanoDrop Technologies Inc., Wilmington, DE) and sample integrity
was determined by the ratio of absorbance at 260 nm to 280 nm. Only samples with a
ratio of 260:280 greater than or equal to 1.8 were used for further analysis. An aliquot of
1 µg of purified RNA from each sample was reverse transcribed to cDNA using an
Omniscript reverse transcriptase kit (Qiagen, Inc., Thousand Oaks, CA), random
decamers (Ambion, Foster City, CA) and oligo-dT (Qiagen, Inc., Thousand Oaks, CA).
Abundance of cDNA for each sample was quantified using real-time PCR, Brilliant III
Ultra-Fast SYBR Green QPCR Master Mix (Agilent Technologies, Inc., Santa Clara,
CA) and primers described below. A no-reverse-transcriptase template control was
formed by combining equal quantities of purified RNA from each sample. A cDNA pool
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was formed from equal quantities of cDNA from each sample and diluted with DNasefree water in a 1:4 dilution series to generate a standard curve. DNase-free water served
as the no-template control. The abundance of PC (EC 6.4.1.1), PCK1 (EC 4.1.1.32), and
18S (NCBI Gene number 493779) mRNA was determined using quantitative real-time
PCR. Primers were as follows: bovine PC, CCACGAGTTCTCCAACACCT (forward),
TTCTCCTCCAGCTCCTCGTA (reverse); and bovine 18S,
ACCCATTCGAACGTCTGCCCTATT (forward),
TCCTTGGATTGTGGTAGCCGTTTCT (reverse). Reactions were as follows: 1 cycle at
95°C for 3 min; 40 cycles of 95°C for 10 s, 60°C for 20 s; and 1 cycle of 95°C for 1 min,
55°C for 30 s, and 95°C for 30 s. Reaction efficiencies were between 90% and 110%
based on standard curve analysis. All samples, standards, and controls were analyzed in
triplicate and mean values normalized to 18S mRNA abundance within each sample.
Data are expressed as arbitrary units of mRNA relative to 18S abundance within sample.
Abundance of 18S mRNA (Ct values) was not affected by treatment (P = 0.76).

Assessment of Cellular Integrity
To assess the effects of cell manipulation and fatty acid treatments on viability,
MDBK cells were plated on 96-well cell culture plates and grown to 80% confluence.
Media was changed after 24 h and cells were incubated for 24 h at 37° and exposed to the
same treatment media used for assessment of RNA expression. The TACS MTT Cell
Proliferation Assay (Trevigen, Gaithersburg, MD) was used according to the
manufacturer’s directions to determine the effect of fatty acid treatment on cell viability.

61
Statistical Analysis
Data were analyzed for normality using the Univariate procedure of SAS 9.3
(SAS Institute Inc., Cary, NC). Analyses of variance was performed using the Proc
Mixed procedure of SAS. The model accounted for the fixed effects of treatment and the
random effects of cell replicate. Means were considered different when P < 0.05 and
tended to differ if 0.05 ≤ P ≤ 0.10. Tukey-Kramer studentized adjustments were used for
multiple comparisons to separate treatment means. Data are reported as least squares
means with associated standard errors. Data from Experiment 1 and Experiment 2 were
analyzed separately.

RESULTS AND DISCUSSION

Madin-Darby bovine kidney (MDBK) cells are used here to examine regulation of
bovine PC mRNA expression by fatty acids and their combinations. The MDBK cell
model has been used previously to study control of enzymes for gluconeogenesis and
fatty acid metabolism, including PC (Bionaz et al., 2008a,b; Thering et al., 2009; White
et al., 2012). Expression patterns of periparturient cow liver tissue and MDBK
transcriptomes showed strong similarities (Bionaz et al., 2008b). Furthermore, response
to long-chain fatty acids and to peroxisome proliferator-activated receptor agonist
(PPAR) agonist have been evaluated in MDBK cells (Bionaz et al., 2008a). This cell
culture system was most recently used to analyze transcript abundance of glucogenic
genes after treatment with fatty acid profiles that mimic circulating NEFA profiles in
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dairy cows during the periparturient period, or under a model of induced fatty liver
(White et al., 2012).
Analysis of cellular integrity after fatty acid treatments on MDBK cells by TACS
MTT Cell Proliferation Assay indicated a significant (P < 0.05) reduction in cell viability
of 13.12%, 15.78%, 12.26%, and 8.7% with the addition of 1.00 mM C16:0, C18:0,
C18:1n-9 cis, or C18:3n-3 cis, respectively, compared to viability levels of 10% FBStreated controls in MDBK cells. Treatments with each fatty acid alone, at all evaluated
concentrations (0.25 mM, 0.50 mM, 0.75 mM, or 1.00 mM) did not differ (P > 0.10) in
viability compared to the 10% FBS or 1% BSA treatments (Figure 2.1). Treatments with
each fatty acid alone, at all evaluated concentrations (0.25 mM, 0.50 mM, 0.75 mM, or
1.00 mM) showed a slight, but significant decrease (P < 0.05) in viability compared to the
combination of C18:3n-3 cis at any evaluated ratio (Figure 2.1). Despite the effects of
single fatty acids, any evaluated combination of two fatty acids did not differ (P > 0.10)
for cell viability measurement from the control 1% BSA DMEM or 10% FBS DMEM
media (Figure 2.1). This indicates a more optimal environment for cellular growth and
proliferation occurs when any two of the fatty acids evaluated here are present in the
treatment media for MDBK cells.
Previous work in the human hepatoblastoma HepG2 cell line demonstrated a high
percentage of apoptosis, measured with DAPI (4’,6-diamidino-2-phenylindole
dihydrochloride), after 24 h treatment with 0.66 mM C16:0 (Ricchi et al., 2009). Percent
apoptosis was significantly reduced when C18:1n-9 cis was added to treatment media,
even when total treatment concentrations equaled 1.0 or 2.0 mM (Ricchi et al., 2009).
Similarly, when evaluated in a model of hepatic steatosis, human hepatocytes exhibited
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decreased cell viability after treatment with C16:0 alone (Chen et al., 2014). In the same
study, treatments containing combinations of C16:0 with C18:1n-9 cis were able to
reduce the C16:0-induced inhibition of cell growth (Chen et al., 2014). Treatment
combinations of C16:0 with C18:1n-9 cis were not evaluated in the current study. Fatty
acid treatments combining C18:0 with C18:3n-3 cis have been studied in isolated rat
primary hepatocytes (Zhang et al., 2011). While exposure of hepatocytes to 0.25 mM
C18:0 significantly reduced MTT-measured cellular viability, co-treatment of 0.25 mM
C18:0 with either 0.15 mM or 0.25 mM C18:3n-3 cis restored viability measurement to
levels similar to the control (Zhang et al., 2011). This knowledge base, combined with
data from the current study, indicates that co-incubation with more than one fatty acids
allows greater cellular viability, potentially from more closely mimicking in vivo
circulating fatty acid concentrations. Consequently, these data support the value of any
effects of fatty acid combinations on PC expression or other transcripts. While decreases
are seen in cellular viability in the current study under single fatty acid treatments,
compared to treatment combinations of fatty acids, these decreases did not occur from
treatments containing multiple fatty acids. Therefore, gene expression data, discussed
below, are not likely attributed to differences in viability and are the result of fatty acid
treatment.
Treatment with C16:0 or C18:0 independently decreased (P < 0.05) PC mRNA
expression compared to either C18:3n-3 cis treatment alone or the control of no
additional fatty acid in MDBK cells (Figure 2.2). In contrast, exposure to C18:1n-9 cis or
C18:3n-3 cis treatment alone did not differ (P > 0.10) from the control (Figure 2.2) in
MDBK cells. Previous research in the MIN6 mouse pancreatic β-cell line demonstrated a
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significant decrease in PC transcript abundance after 48 h treatment with either 0.4 mM
C16:0 or 0.4 mM C18:1n-9cis (Busch et al., 2002). In the current study, a differential
response is clearly seen in PC mRNA expression after treatment with saturated,
compared to mono- or polyunsaturated fatty acids alone. The bovine PC gene contains
three promoters (Agca et al., 2004) and expresses six 5’ untranslated region variants that
are transcribed from these promoters (Hazelton et al., 2008). PC expression regulation by
fatty acids occurs through activation of promoter 1 (White et al., 2011a). Specifically,
responsiveness of PC promoter 1 to C18:0 was established where depression of promoter
1 occurred with increasing concentrations, up to 1.0 mM, of C18:0 (White et al., 2011b).
While the current study examines PC mRNA expression, it is clear that some regulation
by fatty acids occurs. Whether this regulation occurs through changes in transcription
factor binding or through metabolic influences remains to be elucidated.
To determine the dominance of control of PC mRNA expression by saturated or
unsaturated fatty acids in MDBK cells, combinations of fatty acids in 10:90, 25:75,
50:50, or 75:25 molar ratios from combinations of C16:0: C18:3n-3 cis, and in 25:75,
50:50, 75:25, or 90:10 molar ratios from combinations of C18:0: C18:3n-3 cis, or
C18:1n-9 cis: C18:3n-3 cis were examined for their potential influence on PC mRNA
expression. The ratio of 75:25 C16:0: C18:3n-3 cis significantly increased (P < 0.05) PC
expression compared to C16:0 alone, though values were still significantly lower (P <
0.05) than either C18:3n-3 cis treatment alone or the control of no additional fatty acid.
Ratios of 50:50, 25:75, or 10:90 for C16:0: C18:3n-3 cis were able to significantly (P <
0.05) recover PC mRNA expression in MDBK cells to levels similar to control or
C18:3n-3 cis treatment. Regulation through C18:3n-3 cis is therefore stronger than
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regulation through C16:0 as when these two fatty acids were present in equal ratios in the
treatment media, PC mRNA expression was similar to expression after 1.0 mM C18:3n-3
cis treatment, and greater than expression after 1.0 mM C16:0 treatment. Fatty acid
combinations of 75:25, 50:50, or 25:75 C18:0: C18:3n-3 were able to significantly (P <
0.05) recover PC mRNA expression to levels similar to control or C18:3n-3 cis treatment
in MDBK cells. Again, the dominance of control on PC gene expression can be seen in
response to lesser ratios of C18:3n-3 cis. Combinations of C18:1n-9 cis with C18:3n-3 cis
in any ratio did not significantly (P > 0.05) alter PC mRNA expression in MDBK cells
(Figure 2.2). Interestingly, a recent study examining the responsiveness in MDBK cells
of several genes involved in gluconeogenesis and fatty acid oxidation, including PC, after
6 h exposure to several different long-chain fatty acids showed no change in PC mRNA
expression after treatment with either C16:0, C18:0, C18:1n-9 cis, or C18:3n-3 cis
compared to control (Bionaz et al., 2012.) However, only single fatty acid treatments at
0.15 mM were interrogated (Bionaz et al., 2012.). Additionally, an in vivo experiment
examined effects of supplemental long-chain fatty acids from either saturated fat sources
(Energy Booster) or fish oil supplements from around 25 d before calving to 10 d
postpartum (Akbar et al., 2013). Pyruvate carboxylase mRNA expression was increased
in liver biopsy samples from the control group (no supplemental long-chain fatty acids)
postpartum compared to prepartum, while PC mRNA expression was unchanged pre- to
postpartum with either peripartal fat supplement, but was significantly lower than control
(Akbar et al., 2013). Concurrently, lower concentrations of C18:3n-3 cis in liver
phospholipids at 10 d prepartum were recorded in both fat supplemented groups
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compared to control (Akbar et al., 2013), which further supports the relationship between
liver C18:3n-3 cis concentration and PC mRNA expression.
Fatty acid treatments, in any examined combination, in bovine hepatocytes did
not elicit a significant response in PC mRNA expression (P > 0.10; Figure 2.3). When PC
mRNA expression in response to only single fatty acid treatments and control 1% BSA is
examined, treatment with C18:3n-3 cis alone did significantly increase (P < 0.05) PC
mRNA expression compared to the control or saturated fatty acid treatment (1.86, 1.00,
1.04, and 0.66 ± 0.17 for C18:3n-3 cis, 1% BSA DMEM control, C16:0, and C18:0,
respectively). These data differ from the response seen in MDBK cells in that C18:3n-3
cis numerically increases PC mRNA expression to levels greater than 1% BSA DMEM
control in primary hepatocytes. As the duration of treatment was identical, this difference
may be due, in part, to the sensitivity of hepatocytes to unsaturated fatty acids, compared
to MDBK cells. Previous work examined response of bovine hepatocytes to long-term
fatty acid treatments over a 48 h period and found influences of fatty acids on glucose
metabolism (Mashek and Grummer, 2003). Treatments that included C18:3n-3 cis
increased gluconeogenesis and decreased triglyceride deposition, though PC was not
evaluated (Mashek and Grummer, 2003). Longer incubation periods may be necessary to
elicit a greater response to fatty acids in primary hepatocytes. The MDBK cell model
may be more sensitive to fatty acid uptake as the 24 h treatment period was adequate in
this model. Accordingly, we must also consider that primary hepatocytes are exposed to
circulating fatty acid concentrations in vivo, before harvest, and were weaned off of that
profile after isolation, while the MDBK cells are cultured in a background media
containing very low fatty acid levels.
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Carboxylation of pyruvate to OAA by PC maintains the pool of OAA available
for use in the TCA cycle. Maintaining or increasing this pool is necessary to promote
oxidative capacity in the cell. Any increase in the OAA pool that is generated by PC may
be opposed by enzymes that pull carbons out of the OAA pool, specifically in
gluconeogenesis by PCK1 and PCK2. Pyruvate carboxylase enzyme activity in bovine
has been previously correlated with PC mRNA expression (Greenfield et al., 2000).
Therefore, if activity of PC increases, and this increase is not matched by PCK activity,
then an increase in potential cycling and oxidative capacity of the TCA may occur.
Elevated PC expression and activity at calving in the absence of changes in PCK1
(Greenfield et al., 2000) would favor an increased oxidative capacity and may be part of
the adaptations that enable transition cows to metabolize greater quantities of fatty acids
in liver.
Mobilization of adipose tissue stores during negative energy balance around
parturition is necessary to meet increased energy demand. Inability to cope with this
increased NEFA load can lead to development of ketosis or fatty liver (Vernon, 2005).
The circulating NEFA profile as well as concentration at calving are influenced by diets
fed to dry cows (Rukkwamsuk et al., 2000). Increases in C16:0 and C18:1, presumably
from adipose tissue lipolysis, were elevated in liver of cows with fatty liver compared to
control animals (Rukkwamsuk et al., 2000). Changes in circulating NEFA and the
activation of glucogenic enzymes have also been previously linked in nonruminants
(Pawar and Jump, 2003). Long chain fatty acids are known activators of transcription
factors, including PPARα, that regulate genes for gluconeogenesis (Pawar and Jump,
2003). While exposure to Wy14643 (a PPARα agonist) at 0.10 mM in rat hepatoma cells
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has previously been shown to increase the activity of a transfected bovine PC promoter 1
(White el al., 2011b), no change in PC mRNA expression was seen in MDBK cells
exposed for 6 h to 0.15 mM Wy14643 (Bionaz et al., 2012). Effects of other PPARα
agonists, or the direct effects of unsaturated fatty acids on PC mRNA expression remain
uncertain.
The fatty acid concentrations of 1.0 mM tested in the present study are relevant
with regards to total circulating concentrations of NEFA in dairy cows around the time of
parturition (Rukkwamsuk et al., 1999), but are not directly applicable to most
physiological settings because adipose triglycerides and dietary lipids are rarely
comprised of a single fatty acid. However, during the negative energy balance associated
with transition to lactation, plasma NEFA profiles consist predominantly of C16:0,
C18:0, and C18:1 (Rukkwamsuk et al., 1999). Shifts that occur in the profile of plasma
fatty acids may influence expression of genes responsible for gluconeogenesis or fatty
acid metabolism. An increase in the concentration of plasma C18:0 has been reported in
periparturient dairy cows (Rukkwamsuk et al., 1999). While C18:1 levels are similar
during the pre- or post-partum periods, C18:0 levels show a peak at calving
(Rukkwamsuk et al., 1999; Douglas et al., 2007). Increases in plasma NEFA also occur
after supplementation with calcium soaps of long-chain fatty acids (Megalac-R)
compared to controls (Moallem et al., 2007). Dairy cows receiving 230 g/d Megalac-R
during the dry period and 215 g/d Megalac-R postpartum until 100 DIM had significantly
higher plasma NEFA levels postpartum compared to cows receiving a control dry cow
diet without supplemental fatty acids (Moallem et al., 2007). Similarly, supplementation
of dry cow diets with calcium soaps of fatty acids from 30 d before calving through 100 d
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postpartum increased plasma NEFA and BHBA levels compared to cows receiving
hydrogenated palm oil triglyceride at equal net energy supply during the same period
(Karcagi et al., 2009). Although neither of these studies were specifically designed to
examine the influences of dietary fat on plasma fatty acid profile, data is available
indicating the effect of feeding whole flaxseed, a source of polyunsaturated fatty acids,
on plasma NEFA profiles (Petit, 2002). Postpartum diets containing flaxseed increased
plasma C18:1n-9 cis and C18:3n-3 cis levels compared to plasma levels in cows
receiving postpartum diets supplemented with micronized soybeans (Petit, 2002). Data
from the current study indicate that stearic acid directly depresses bovine PC mRNA
expression and suggest that the ratio of saturated to unsaturated plasma fatty acids
regulate changes in PC mRNA around calving. When combined with observations of
changes in fatty acid profiles at calving with diet and predisposing physiological states, a
working hypothesis emerges that dietary fatty acid profile can determine PC expression
to potentially alter the cellular OAA pool. Additional work is needed to better
characterize the interplay between these fatty acids and potential effects on bovine liver.
Results presented in the current study indicate that C18:3n-3 cis is a more potent
alleviator of PC mRNA depression in C18:0: C18:3n-3 cis treated MDBK cells compared
to C16:0: C18:3n-3 cis treatments. C18:1n-9 cis treatments did not depress PC mRNA
expression, revealing that fatty acid saturation is key in fatty acid regulation of PC
expression. These data indicate a potential differential response of unsaturated or
saturated fatty acids to signals induced by fatty acid treatments.
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CONCLUSIONS

Results indicate a significant depression of PC mRNA expression in MDBK cells
after 24 h treatment with either C16:0 or C18:0. Inclusion of C18:3n-3 cis in treatment
media, in the higher evaluated ratios, proved to successfully ameliorate this depression
and recover PC mRNA expression to levels similar to control. Response of bovine
hepatocytes to fatty acid exposure was muted, possibly due to duration of treatment, but
PC mRNA expression did increase in bovine hepatocytes after C18:3n-3 cis, compared to
single saturated fatty acid treatment or to control. PC activation by unsaturated fatty acids
may play a critical role in setting the capacity for OAA synthesis. Both fatty acid chain
length and degree of saturation appear to be key in regulation of PC mRNA expression
by fatty acids.
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Figure 2.1. Effect of 24 h fatty acid treatments on cellular viability in Madin-Darby
bovine kidney (MDBK) cells. To assess the effects of cell manipulation and fatty acid
treatments on viability, cells were plated on 96-well cell culture plates and grown to 80%
confluence. Media was changed after 24 h and cells were incubated for 24 h at 37° and
exposed to treatment media. Fatty acid treatments were either single fatty acids (C16:0,
C18:0, C18:1n-9 cis, or C18:3n-3 cis) or combinations of C16:0 with C18:3n-3 cis, or
C18:0 with C18:3n-3 cis, or C18:1n-9 cis with C18:3n-3 cis, in the molar ratios indicated.
All treatments totaled 1.0 mM in Dulbecco’s Modified Eagle’s Medium (DMEM) with
1% BSA. Control cells were incubated in DMEM with 1% BSA and no additional fatty
acid. The TACS MTT Cell Proliferation Assay (Trevigen, Gaithersburg, MD) was used
according to the manufacturer’s directions to determine the effect of fatty acid treatment
on cell viability. Data are reported as least squares means with associated standard errors.
Within panel, means without a common superscript differ (P < 0.05).
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Figure 2.2. Effect of 24 h exposure to fatty acids on expression of pyruvate carboxylase
(PC) mRNA in Madin-Darby bovine kidney (MDBK) cells. MDBK cells at 80%
confluence were cultured with BSA-bound fatty acids (FA) for 24 h. Fatty acid
treatments were either single fatty acids (C16:0, C18:0, C18:1n-9 cis, or C18:3n-3 cis) or
combinations of C16:0 with C18:3n-3 cis (top), or C18:0 with C18:3n-3 cis (middle), or
C18:1n-9 cis with C18:3n-3 cis (bottom), in the molar ratios listed. All treatments totaled
1.0 mM in Dulbecco’s Modified Eagle’s Medium (DMEM) containing 1% BSA. Control
treatment is DMEM with 1% BSA and no added fatty acid. Data are presented as ratio of
PC:18S mRNA expression in arbitrary units (AU) and reported as least squares means
with associated standard errors. Within panel, means without a common superscript differ
(P < 0.05).
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Figure 2.3. Effect of 24 h exposure to fatty acids on expression of pyruvate carboxylase
(PC) mRNA in bovine primary hepatocytes. Twenty hours after seeding plates,
hepatocytes were exposed to BSA-bound fatty acids (FA) for 24 h and then harvested for
mRNA analysis. Fatty acid treatments were either single fatty acids (C16:0, C18:0, or
C18:3n-3 cis) or combinations of C16:0 with C18:3n-3 cis (top), or C18:0 with C18:3n-3
cis (bottom), in the molar ratios listed. All treatments totaled 1.0 mM in Dulbecco’s
Modified Eagle’s Medium (DMEM) containing 1% BSA. Control treatment is DMEM
with 1% BSA and no added fatty acid. Data are presented as ratio of PC:18S mRNA
expression, relative to 1% BSA DMEM control, in arbitrary units (AU) and reported as
least squares means with associated standard errors. Within panel, means without a
common superscript differ (P < 0.05). Analysis of PC mRNA expression in response to
only single fatty acid treatments and control 1% BSA determined treatment with C18:3n3 cis alone significantly increased (P < 0.05) PC mRNA expression compared to the 1%
BSA DMEM control or saturated fatty acid treatment (1.86, 1.00, 1.04, and 0.66 ± 0.17
for C18:3n-3 cis, 1% BSA DMEM control, C16:0, and C18:0, respectively).
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CHAPTER 3. PRETREATMENT WITH SATURATED AND UNSATURATED
FATTY ACIDS REGULATES SUBSEQUENT PALMITATE METABOLISM
IN MADIN-DARBY BOVINE KIDNEY CELLS

ABSTRACT

Metabolic fates of fatty acids in tissue may be influenced by extracellular
concentration and profile of fatty acids. Previous work has demonstrated an ability of
C18:3n-3 cis to ameliorate the effects of C16:0- or C18:0-induced depression of pyruvate
carboxylase (PC) mRNA expression. Pyruvate carboxylase catalyzes oxaloacetate (OAA)
synthesis and connects gluconeogenesis from lactate and fatty acid metabolism. Our
objective was to determine the effects of a copresence of saturated and unsaturated fatty
acids on cellular partitioning of [1-14C]C16:0 metabolism to CO2 or acid-soluble products
(ASP) in Madin-Darby bovine kidney (MDBK) cells and the role of PC in this
relationship. We hypothesized that the ratio of saturated to unsaturated fatty acid
pretreatments regulates [1-14C]C16:0 partitioning to CO2 or ASP. Cells were exposed for
21h to either individual fatty acids, C16:0, C18:0, C18:1n-9 cis or C18:3n-3 cis, or to
fatty acid combinations in 10:90, 25:75, 50:50, 75:25 or 90:10 ratios for combinations of
C16:0: C18:3n-3 cis or C18:0: C18:3n-3 cis or C18:1n-9 cis: C18:3n-3 cis. Total fatty
acid concentration was 1.0 mM during the 21 h pretreatment phase. Following the 21 h
incubation phase with fatty acid combinations, cells were incubated in the presence of 1.0
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mM [1-14C]C16:0 for 3h to determine the rate of metabolism to CO2 and ASP collection
per h ∙ µg DNA-1. Pretreatments with either C16:0 or C18:0 alone significantly (P < 0.01)
depressed subsequent oxidation of [1-14C]C16:0 to ASP by 62.7% and 41.2%,
respectively, compared to C18:3n-3 cis pretreatments. Similar patterns were observed for
[1-14C]C16:0 oxidation to CO2. Expression of PC mRNA was significantly decreased (P
< 0.05) with exposure to either C16:0 or C18:0, compared to expression after exposure to
either C18:3n-3 cis or control 1% BSA DMEM. Expression of cytosolic
phosphoenolpyruvate carboxykinase (PCK1) mRNA followed a similar pattern. Fatty
acid treatments containing C18:1n-9 cis did not alter PC or PCK1 expression from
control or C18:3n-3 cis results. Pearson’s coefficient correlations were determined for PC
mRNA expression and rate of [1-14C]C16:0 metabolism to CO2 or ASP, including
ketones, and for PCK1 mRNA expression and rate of [1-14C]C16:0 metabolism to CO2 or
ASP. Production of CO2 from [1-14C]C16:0 positively correlated (r = 0.63; P < 0.05) with
PC expression, while ASP production from [1-14C]C16:0 only tended to positively
correlate (r = 0.51; 0.05 < P < 0.10) with PC mRNA expression. Production of CO2 or
ASP from [1-14C]C16:0 both positively correlated (r = 0.80; r = 0.69, respectively; P <
0.05) with PCK1 expression. Results show a regulation of ketone production by MDBK
cells in response to saturated and unsaturated fatty acid pretreatments.

Keywords: bovine, fatty acid oxidation, ketogenesis
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INTRODUCTION

Pyruvate carboxylase (PC; EC 6.4.1.1) is a critical enzyme, responsible for the
anaplerotic regeneration of tricarboxylic acid cycle (TCA) intermediates. Conversely,
phosphoenolpyruvate carboxykinase (PCK; EC 4.1.1.32) acts to cataplerotically drain
carbon intermediates from TCA cycle towards gluconeogenesis. Pyruvate carboxylase is
responsible for the carboxylation of pyruvate to oxaloacetate (OAA), which subsequently
condenses with acetyl-CoA in the first step of the TCA cycle, therefore, the capacity for
fatty acid oxidation as well as gluconeogenesis is dependent upon the OAA status within
the cell. As a result, the maintenance of the OAA pool through the action of PC flux
could promote complete oxidation of acetyl-CoA in the TCA cycle, providing PCK1 and
PCK2 activities do not exceed PC flux (Jitrapakdee et al., 2006).
Nutritional control of PC is well established in rats (Bizeau et al., 2001), mice
(Hagopian et al., 2004), and lactating dairy cows, specifically during a period of imposed
feed restriction (Velez and Donkin 2005), and transition to lactation (Greenfield et al.,
2000). In periparturient dairy cows, plasma nonesterified fatty acid (NEFA)
concentrations increase in response to the negative energy balance experienced around
calving. After calving, plasma NEFA concentrations in excess of 1.5 mM are observed
and contrast to concentrations near 0.2 mM during the prepartum period (Rukkwamsuk et
al., 2000). Circulating NEFA are taken up by liver in proportion to their presence in
blood (Emery et al., 1992) and are either metabolized through either complete or partial
oxidation, or triglyceride synthesis and either deposition or loading onto very low density
lipoprotein (VLDL) particles for export (reviewed by Drackley et al., 2001; Bobe et al.,
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2004; van Knegsel et al., 2005). Ruminants and nonruminants differ with respect to
hepatic capacity for VLDL export, with the rate of export by nonruminants being 25
times the capacity of VLDL export for ruminants (Kleppe et al., 1988). Increases in
triglyceride synthesis thus put dairy cows at increased risk for developing ketosis and
fatty liver. Furthermore, overfeeding during the prepartum interval is linked to a decrease
in the activity of hepatic enzymes involved in NEFA oxidation (Murondoti et al., 2004),
and a decrease in the rate of C16:0 oxidation to CO2 (Litherland et al., 2011). Strategies
to alleviate these pathways of fatty acid metabolism and promote alternative fatty acid
oxidative pathways could potentially decrease susceptibility to these metabolic disorders.
The role of PC mRNA expression in relation to the potential for cellular complete
or partial fatty acid oxidation remains unclear. Our objective was therefore to determine
effects of copresence of saturated and unsaturated fatty acid pretreatments on cellular
partitioning of [1-14C]C16:0 metabolism to CO2 or acid-soluble products (ASP) in MadinDarby bovine kidney (MDBK) cells, a bovine model cell line for the study of cellular
energy metabolism. We hypothesized that the ratio of saturated to unsaturated fatty acid
pretreatments regulates [1-14C]C16:0 partitioning to CO2 and ASP.

MATERIALS AND METHODS

Cell Culture
Madin-Darby bovine kidney epithelial cells (NBL-1 ATCC CCL-22) were
obtained at passage 110 from the American Type Culture Collection (ATCC, Manassas,
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VA). Cells were propagated in sterile polystyrene 150-cm2 canted-neck, 0.2 µm vent cap
flasks (Corning, Corning, NY) in Dulbecco’s Modified Eagle’s Medium (DMEM)
containing 1 g/L D-glucose, L-glutamine, and 110 mg/L sodium pyruvate (Life
Technologies, Grand Island, NY) supplemented with 10% fetal bovine serum (FBS;
Sigma-Aldrich Corp., St. Louis, MO), 100 units/mL penicillin, 100 µg/mL streptomycin,
and 250 ng/mL amphotericin B (Antibiotic-Antimycotic Solution; Sigma-Aldrich Corp.,
St. Louis, MO) at 37°C in 5% CO2 and 95% air. Media was refreshed every two to three
d. Cells were subcultured to near confluence following media removal with trypsinEDTA (Sigma-Aldrich Corp., St. Louis, MO). Trypsin activity was inhibited by addition
of 10 mL of fresh DMEM supplemented with 10% FBS (Sigma-Aldrich Corp.), 100
units/mL penicillin, 100 µg/mL streptomycin, and 250 ng/mL amphotericin B
(Antibiotic-Antimycotic Solution; Sigma-Aldrich Corp.). For each experimental
replicate, cells were plated onto 35-mm Falcon Primaria Easy Grip tissue culture dishes
(Becton Dickinson, Lincoln Park, NJ) at a density of 5 × 105 cells per well and incubated
in 10% FBS DMEM with antibiotics, as indicated above, to achieve approximately 80%
confluence before exposure to treatments.

Fatty acid pretreatments
Fatty acids C16:0, C18:0, C18:1n-9 cis, C18:3n-3 cis (Sigma-Aldrich Corp.) were
bound to BSA (Probumin; Millipore, Billerica, MA) in a 4:1 molar ratio as described
previously (Berry et al., 1991). Cells at 80% confluence were cultured in DMEM and
exposed for 21 h to either 1% BSA (no addition control), or to 1.0 mM individual fatty
acid (bound to BSA), or to combinations of fatty acids in 10:90, 25:75, 50:50, or 75:25
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molar ratios from combinations of C16:0: C18:3n-3 cis, and in 25:75, 50:50, 75:25, or
90:10 molar ratios from combinations of C18:0: C18:3n-3 cis, or C18:1n-9 cis: C18:3n-3
cis. Total fatty acid concentration in each combination was 1.0 mM and BSA
concentration was 1%. Pretreatments were applied in triplicate to three separate cell
replicates.

Measurement of metabolic flux
Following exposure to pretreatments for 21 h, cells were incubated in the
presence of DMEM containing 1% BSA and 1.0 mM [1-14C]C16:0 for 3h before CO2 and
ASP collection, as previously described (Donkin and Armentano, 1994). Briefly,
pretreatment media was removed and each 35-mm dish (base) was placed into a straightside wide-mouth 60-mL jar (Nalgene, Thermo Scientific, Waltham, MA) with lids
modified to hold rubber plug-type stoppers (Kimble Chase, Vineland, NJ) and fitted with
a hanging plastic center well (Kimble Chase, Vineland, NJ). MDBK cells were then
incubated in DMEM containing 1% BSA and 1.0 mM BSA-bound C16:0 containing 114

C labelled C16:0 (Perkin Elmer, Waltham, MA) at approximately 1,000,000 DPM per

flask. Cells were gassed with 95% O2 : 5% CO2, immediately sealed and incubated at
37°C for 3 h. Incubations were terminated by the addition of 0.2 mL of 5N HClO4
injected through the stopper of the flask into the media. A volume of 0.2 mL
phenethylamine was added to each hanging center well containing a filter paper wick to
trap 14CO2. Samples were incubated for 1 h at room temperature after which center wells
were removed, placed in scintillation vials with scintillation cocktail (Ecolite; MP
Biomedical LLC, Solon, OH), and radioactivity determined by liquid scintillation
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counting. The rate of fatty acid incorporation into ASP was determined from acidified
media. Media was removed from plates, collected in 15 mL conical tubes and plates were
rinsed 2× with ice cold saline and the saline rinse combined with acidified media. The
collected media and saline mixture was centrifuged for 10 min at 700 × g, neutralized
with KOH, and radioactivity determined by liquid scintillation counting. DNA content of
each culture plate was determined as previously described (Labarca and Paigen, 1980).
The rate of oxidation was determined and expressed as nmol 14C substrate metabolized to
CO2 • μg DNA-1 • h-1. The rate of synthesis of ASP, including ketones, is expressed as

14

nmol 14C substrate incorporated in ASP • μg DNA-1 • h-1.

Cell Sample Collection, RNA Isolation, and Transcript Quantification
A parallel incubation was completed utilizing the same passage of cells
interrogated for the oxidation experiment. Cells were exposed to C16:0: C18:3n-3 cis or
C18:0: C18:3n-3 cis fatty acid treatment combinations in the molar ratios describe above.
After exposure to treatments for 24 h, media was removed and cells were disrupted and
lysed by adding 350 µL Buffer RLT (RNeasy Mini Kit, Qiagen Inc., Germantown, MD).
Plates were shaken on an orbital shaker (Barnstead International, Dubuque, IA) for 10
minutes and cell lysates collected to a 1.5 mL microcentrifuge tube. Lysates were stored
at -80°C until subsequent RNA isolation.
Cell lysates were homogenized by vortexing and processed using the RNeasy
Mini Kit according to manufacturer directions (Qiagen Inc., Germantown, MD). Purified
RNA was quantified for each sample by absorbance at 260 nm using a ND-1000
spectrophotometer (NanoDrop Technologies Inc., Wilmington, DE) and sample integrity
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was determined by the ratio of absorbance at 260 nm to 280 nm. Only samples with a
ratio of 260:280 greater than or equal to 1.8 were used for further analysis. An aliquot of
1 µg of purified RNA from each sample was reverse transcribed to cDNA using an
Omniscript reverse transcriptase kit (Qiagen, Inc., Thousand Oaks, CA), random
decamers (Ambion, Foster City, CA) and oligo-dT (Qiagen, Inc., Thousand Oaks, CA).
Abundance of cDNA for each sample was quantified using real-time PCR, Brilliant Ⅲ
Ultra-Fast SYBR Green QPCR Master Mix (Agilent Technologies, Inc., Santa Clara,
CA) and primers described below. The no-reverse-transcriptase template control was
formed by combining equal quantities of purified RNA from each sample. A cDNA pool
was formed from equal quantities of cDNA from each sample and diluted with DNasefree water in a 1:4 dilution series to generate a standard curve. DNase-free water served
as the no-template control. The abundance of PC (EC 6.4.1.1), PCK1 (EC 4.1.1.32), and
18S (NCBI Gene number 493779) mRNA was determined using quantitative real-time
PCR. Primers were as follows: bovine PC, CCACGAGTTCTCCAACACCT (forward),
TTCTCCTCCAGCTCCTCGTA (reverse); bovine PCK1,
AGGGAAATAGCAGGCTCCAGGAAA (forward),
CACACGCATGTGCACACACACATA (reverse); and bovine 18S,
ACCCATTCGAACGTCTGCCCTATT (forward),
TCCTTGGATTGTGGTAGCCGTTTCT (reverse). Reactions were as follows: 1 cycle at
95°C for 3 min; 40 cycles of 95°C for 10 s, 60°C for 20 s; and 1 cycle of 95°C for 1 min,
55°C for 30 s, and 95°C for 30 s. Reaction efficiencies were between 90% and 110%
based on standard curve analysis. All samples, standards, and controls were analyzed in
triplicate and mean values normalized to 18S mRNA abundance within each sample.
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Data are expressed as arbitrary units of mRNA relative to 18S abundance within sample.
Abundance of 18S mRNA (Ct values) was not affected by treatment (P = 0.77).

Statistical Analysis
Data were analyzed for normality using the Univariate procedure of SAS 9.3
(SAS Institute Inc., Cary, NC). Analyses of variance was performed using the Proc
Mixed procedure of SAS. The model accounted for the fixed effects of fatty acid
pretreatment and the random effects of cell replicate. Means were considered different
when P < 0.05 and tended to differ if 0.05 ≤ P ≤ 0.10. Tukey-Kramer studentized
adjustments were used for multiple comparisons to separate treatment means. Data are
reported as least squares means with associated standard errors. Pearson correlation
coefficients for PC mRNA expression and nmol [1-14C]C16:0 substrate conversion to
either CO2 or ASP (per μg DNA-1 • h-1) were obtained using the PROC CORR procedure
of SAS (SAS Institute, Cary, NC).

RESULTS AND DISCUSSION

Use of the Madin-Darby bovine kidney (MDBK) cell line for the current study is
supported by previous studies examining metabolism and activities of enzymes for
gluconeogenesis and fatty acid oxidation (Bionaz et al., 2008a,b; Thering et al., 2009;
White et al., 2012). Notable similarities have been illustrated between mRNA expression
patterns in MDBK cells and liver from periparturient dairy cows (Bionaz et al., 2008b).

90
The metabolic role of kidney to oxidize fatty acids, especially during times of increase
circulating NEFA load (Salto et al., 1996; Huang et al., 2006) further justifies the use of a
kidney cell line for the current substrate oxidation experiments.
Similar to results presented in CHAPTER 2, effects of fatty acids on expression of
PC mRNA were evaluated. Expression of PC mRNA was significantly decreased (P <
0.05) after exposure to 1.0 mM C16:0 or C18:0, compared to mRNA expression after to
exposure to C18:3n-3 cis or to control 1% BSA DMEM (Table 3.1). To ameliorate this
saturated fatty acid-induced depression, treatment ratios greater than or equal to 0.25:0.75
C18:0: C18:3n-3 cis or 0.50:0.50 C16:0: C18:3n-3 cis were required to restore PC mRNA
expression to levels similar (P > 0.10) to those after 1.0 mM C18:3n-3 cis treatment
(Table 3.1). Expression of PC mRNA did not differ (P > 0.10) after exposure, at any
ratio, to C18:1n-9 cis. To better determine to balance of cataplerotic and anaplerotic
response occurring after exposure to fatty acid treatments, PCK1 mRNA expression was
also determined. Expression of PCK1 mRNA was significantly decreased (P < 0.05) after
exposure to 1.0 mM C16:0 or C18:0, compared to mRNA expression after exposure to
C18:3n-3 cis or to control 1% BSA DMEM (Table 3.1). Treatment ratios greater than or
equal to 0.75:0.25 C16:0: C18:3n-3 cis or C18:0: C18:3n-3 cis were required to restore
PCK1 mRNA expression to levels similar (P > 0.10) to those after 1.0 mM C18:3n-3 cis
treatment (Table 3.1). Similar to results from PC mRNA expression, treatments including
any ratio of C18:1n-9 cis did not alter PCK1 mRNA expression. Maintenance of activity
or increase activity of either enzyme, using a proxy measure of mRNA expression
(Greenfield et al., 2000), can be used to infer the pool size available for the cataplerotic
or anaplerotic fate of OAA.
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Fatty acid β-oxidation occurs in both the mitochondria and peroxisome and
effectively shortens fatty acids by two carbons with each cycle. Fatty acid pretreatments
in the current substrate oxidation study with either 1.0 mM C16:0 or C18:0 alone
significantly (P < 0.01) depressed subsequent oxidation of [1-14C]C16:0 to ASP by
62.7% and 41.2%, respectively, compared to C18:3n-3 cis pretreatments in MDBK cells
(Figure 3.1, 3.2). Similar patterns were seen for [1-14C]C16:0 oxidation to CO2. It is well
established in rodent models that polyunsaturated acids are capable of causing increases
in both mitochondrial and peroxisomal oxidation, while leading to a decrease in
esterification to triglycerides (Ikeda et al., 1998; Ide et al., 2000). Early studies in
ruminants examining metabolism of C16:0 to CO2 or ASP using bovine liver slices noted
decreased oxidation to CO2 in liver samples from fasted, compared to control, animals,
while fasting has no effect on C16:0 metabolism to ASP (Jesse et al., 1986). Dairy cows
receiving a high fat diet during the dry period exhibited lower total liver lipid
accumulation and lower liver triglyceride deposition during the postpartum period
compared to cows receiving an isocaloric high grain dry period diet, or to the control
(Grum et al., 1996). The fat source was provided from 50 d prepartum and was comprised
mainly of 42% C18:1n-9 cis, 24% C16:0, 14% C18:0, 8% C18:2n-6 cis, less than 1%
C18:3n-3 cis, and other fatty acid sources (Grum et al., 1996). The same study illustrated
increased prepartum plasma NEFA concentrations, but decreased postpartum plasma
NEFA concentrations in the high fat group, compared to the high grain or control groups
(Grum et al., 1996). While total β-oxidation of C16:0 did not differ in liver tissue samples
taken from the high grain, high fat, or control fed cows, the rate of peroxisomal βoxidation of C16:0 was significantly higher in samples from cows receiving the high fat

92
diet (Grum et al., 1996). Mitochondrial and peroxisomal β-oxidation were not separately
measured in the current study, but peroxisomal β-oxidation has been shown to be
elevated during diabetes and excess NEFA mobilization (Osmundsen et al., 1991). This
suggests that fatty acid β-oxidation is adjustable at transition as a potential mechanism for
transition cows to cope with the excess NEFA load experienced during this period.
Therefore, ways to increase fatty acid β-oxidation through the fatty acid profile to which
cells are exposed is of utmost interest.
Treatment fatty acid levels in the current study totaled 1.0 mM and are consistent
with circulating NEFA levels in transition dairy cows (Rukkwamsuk et al., 1999). In
contrast with a normal physiological setting, treatments of single fatty acids alone are
included in the current study to evaluate the effect of individual fatty acids on subsequent
partitioning and metabolism. Plasma NEFA profiles during the periparturient period are
primarily comprised of C16:0, C18:0, and C18:1 fatty acids, and C18:0 levels have been
shown to peak at calving while C18:1 levels are similar pre- and post-partum
(Rukkwamsuk et al., 1999; Douglas et al., 2007). These data merited selection of the fatty
acids interrogated in the current study.
The ability to increase the cellular capacity for NEFA β-oxidation has been
extensively discussed (Drackley and Andersen, 2006). Potential influences to NEFA
oxidation have been examined through effects of pyruvate (Armentano et al., 1991;
Drackley et al., 1991; Lomax et al., 1983), which raises the question of relationship to PC
activity and links to the current research. Addition of pyruvate to isolated hepatocytes
from fasted and fed sheep stimulated C16:0 complete oxidation to CO2 (Lomax et al.,
1983). Pyruvate was shown to decrease triglyceride accumulation from C18:1n-9 cis in
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isolated hepatocytes from lactating goats (Armentano et al., 1991). A comprehensive
study of biopsy samples from multiparous dairy cows also demonstrated the ability of
pyruvate to increase C16:0 oxidation (Drackley et al., 1991). Any alterations to PC
mRNA expression or enzyme activity concurrent with changes in NEFA metabolism
were not examined in previous studies, so the direct influence of NEFA on PC activity or
flux toward anaplerosis or cataplerosis was not determined.
Previous research in rodents examined the effects of dietary sources of long chain
fatty acids and their influence on β-oxidation (Malewiak et al., 1988; Kumamoto and Ide,
1998). Metabolism of C18:1n-9 cis in isolated hepatocytes from fat-fed rats resulted in an
increase in ASP formation and an increase in esterification to triglycerides compared to
isolated hepatocytes from control animals (Malewiak et al., 1988). While data from the
current study demonstrates significantly (P < 0.05) greater production of ASP from [114

C]C16:0 compared to CO2 for all fatty acid pretreatments examined (Figure 3.1, 3.2,

3.3), production of CO2 from [1-14C]C16:0 was greater after fatty acid pretreatment with
C18:1n-9 cis alone, compared to pretreatment combinations containing C18:3n-3 cis
(Figure 3.3). Interestingly, increased rates of both mitochondrial and peroxisomal C16:0
oxidation are seen in isolated hepatocytes from rats fed a fat mixture high in 18:3n-3 cis,
compared to C16:0 oxidation from rats fed sources of C16:0 or C18:2n-6 cis (Kumamoto
and Ide, 1998), indicating the potential for differences in responses to fatty acids between
ruminants and nonruminants, or differences between in vitro experiments and those
examining dietary fat sources.
Pearson’s coefficient correlations were used to associate PC mRNA expression
and rate of [1-14C]C16:0 metabolism to CO2 or ASP, including ketones. Production of
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CO2 from [1-14C]C16:0 positively correlated (r = 0.63, P < 0.05) with PC expression,
while ASP production from [1-14C]C16:0 only tended to positively correlate (r = 0.51,
0.05 < P < 0.01) with PC mRNA expression (Figure 3.4). Previous research using bovine
primary hepatocytes examined the effects of 3 h exposure to C16:0 alone, or concurrent
exposure to C16:0 combined with several different unsaturated fatty acids, on subsequent
mitochondrial and peroxisomal oxidation (Mashek et al., 2002). Results demonstrate
increased oxidation of fatty acids to CO2 when treatment combinations of C16:0 with
either C20:5n-3 cis (eicosapentaenoic acid; EPA) or C22:6n-3 cis (docosahexaenoic acid;
DHA) were introduced to hepatocytes for 3h, compared to fatty acid treatments of C16:0
alone or C16:0 with C18:1 (Mashek et al., 2002). Similarly, 3 h treatment of bovine
hepatocytes with C16:0 with either C18:3, C20:5n-3 cis, or C22:6n-3 cis reduced total
cellular lipid deposition from C16:0 metabolism (Mashek et al., 2002). Results also
indicated that polyunsaturated fatty acids, including C18:3n-3 cis, were poor substrates
for esterification to triglycerides (Mashek et al., 2002). Although esterification of
substrates to triglyceride formation was not measured in the current study, limitation of
triglyceride formation by C18:3n-3 cis in a primary hepatocyte model illustrates the
potential for promotion through other fates, namely oxidation, of fatty acids after C18:3n3 cis exposure in bovine. While a very similar experiment was completed after 48h
treatments in hepatocyte monolayer cultures, the system did not concurrently measure
complete oxidation to CO2, and only data for ASP production is available (Mashek and
Grummer, 2003). Treatment of bovine hepatocytes with C18:0 included in the treatment
media resulted in the highest rates of ASP production from C16:0 (Mashek and
Grummer, 2003). Taken together, these data indicate a potential role for saturated fatty
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acid in the promotion of substrate metabolism to ASP, perhaps linked to unsaturated fatty
acid as a poor substrate for triglyceride esterification and promotion of substrate
metabolism to CO2.
Studies examining the influence of C18:3n-3 cis on hepatic fatty acid metabolism
in rodents indicate that rats fed linseed oil had increased activity of enzymes involved in
mitochondrial and peroxisomal β-oxidation when fed this source of C18:3n-3 cis (Kabir
and Ide, 1996). Enzymes for fatty acid oxidation were also increased in rats fed C18:3n-3
cis enzyme activity from rats receiving dietary sources of either C18:2n-6 cis or C16:0
(Kumamoto and Ide, 1998). These data further support the role for C18:3n-3 cis in
promoting fatty acid oxidation pathways.
Finally, Pearson’s coefficient correlations were also used to associate PCK1
mRNA expression and rate of [1-14C]C16:0 metabolism to CO2 or ASP. Production of
CO2 or ASP from [1-14C]C16:0 both positively correlated (r = 0.80; r = 0.69,
respectively; P < 0.05) with PCK1 expression (Figure 3.5). Understanding the balance of
PC and PCK1 activities is key to determine the net anaplerotic or cataplerotic pull of
TCA cycle carbons. To maximize the energy production potential of both systems, there
is a need to identify agents or combinations of agents that independently activate PC to
promote fatty acid β-oxidation and TCA cycle capacity. Such an agent would,
simultaneously, maintain, but not increase, PCK1 activity to fulfill the need for carbon
pull to gluconeogenesis.
The present data establish a relationship between regulation of PC mRNA
expression by fatty acids and cellular oxidative capacity. While additional research is
needed to establish the mechanisms through which fatty acids act to modulated PC
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mRNA expression, evidence is accumulating for a role of peroxisome proliferatoractivated receptor α (PPARα). Research on hepatocyte isolations from 7-wk-old calves
after 5 d administration of either fish oil or clofibrate, a PPARα agonist, found an
increased rate of C16:0 conversion to CO2 in 8 h incubations from clofibrate-treated
calves, compared to fish oil- or control-treated hepatocyte isolations (Litherland et al.,
2010), indicating an increase in capacity for fatty acid β-oxidation. An even greater
increase in substrate oxidation to CO2 is seen in lactating goats treated with Wy-14643, a
known PPARα agonist (Cappon et al., 2002). Furthermore, previous research from our
laboratory indicates a response of bovine PC proximal promoter to PPARα agonist
(White et al., 2011). Increased mRNA expression of acyl-CoA dehydrogenase and
PPARα are both during early lactation (Loor et al., 2005) and may link increases in PC at
calving to elevated fatty acid β-oxidation in transition cows. In further support of this
aspect, increases in mRNA expression for genes involved in fatty acid β-oxidation,
including acyl-CoA synthetase long chain, carnitine palmitoyl-transferase 1A, and acylCoA dehydrogenase very long chain, are seen after parturition in liver samples from
transition dairy cows (Loor, 2010; Weber et al., 2013).
A working hypothesis for role of PC in determining cellular partitioning of fatty
acid metabolism to either complete or partial oxidation is supported by the correlation of
PC mRNA expression to substrate oxidation to CO2. Additional experiments are needed
to determine if a similar relationship holds for bovine liver as for the MDBK cell model
examined here.
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CONCLUSIONS

Results show a regulation of ketone production by MDBK cells in response to
saturated and unsaturated fatty acid pretreatments. While oxidation of [1-14C]C16:0 to
either CO2 or ASP was depressed by treatments with saturated fatty acids C16:0 or C18:0
alone, correlation of CO2 values to PC mRNA expression does indicate potential for
increased anaplerotic flux of substrates through PC, but the tendency for correlation of
ASP oxidation values to PC mRNA expression infers either inadvertent activation of
enzymes involved in ketogenesis, or activation of other enzymes, including PCK1,
involved in gluconeogenesis.
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Table 3.1. Pyruvate carboxylase (PC) and cytosolic phosphoenolpyruvate carboxykinase (PCK1) mRNA expression after 24 h
exposure to fatty acid treatments in Madin-Darby bovine kidney (MDBK) cells.

Transcript2
PC
PCK1

C16:0
C18:3n-3 cis

0.00
0.00
2.42a
2.13a,b

1.00
0.00
0.36c
0.25e

Fatty acid treatment ratio1
0.90
0.75
0.50
0.10
0.25
0.50
3
b
ND
1.33
1.97ab
ND
1.02d
1.65bcd

C18:0
C18:3n-3 cis

0.00
0.00
2.42a
2.13b,c

1.00
0.00
0.13b
0.06e

Fatty acid treatment ratio
0.90
0.75
0.50
0.10
0.25
0.50
0.46b
2.01a
2.13a
0.59de
1.28d
1.60cd

0.25
0.75
2.26a
3.19a

0.10
0.90
ND
ND

0.00
1.00
2.29a
2.53ab

0.32
0.30

0.00
0.00
2.42
2.13

1.00
0.00
2.34
2.02

Fatty acid treatment ratio
0.90
0.75
0.50
0.10
0.25
0.50
2.13
2.27
2.09
1.98
1.87
1.92

0.25
0.75
2.51
2.28

0.10
0.90
ND
ND

0.00
1.00
2.29
2.53

0.39
0.44

PC
PCK1

C18:1n-9 cis
C18:3n-3 cis
PC
PCK1

0.25
0.75
2.41a
2.17abc

0.10
0.90
2.36a
2.31ab

0.00
1.00
2.29a
2.53a

SEM
0.36
0.27

a-e

Within fatty acid treatment ratio panel, means with different superscripts within transcript are significantly different (P < 0.05).

1

Fatty acid treatments were either single fatty acids (C16:0, C18:0, C18:1n-9 cis, or C18:3n-3 cis) or combinations of C16:0 with
C18:3n-3 cis (top), or C18:0 with C18:3n-3 cis (middle), or C18:1n-9 cis with C18:3n-3 cis (bottom) in the molar ratios listed. All
treatments totaled 1.0 mM in Dulbecco’s Modified Eagle’s Medium (DMEM) with 1% BSA. Control treatment is DMEM with 1%
BSA and no additional fatty acid.
2

Data are presented as ratio of PC:18S mRNA expression or ratio of PCK1:18S mRNA expression (Arbitrary Units). Data are
reported as least squares means with associated standard errors.
3

ND : Not determined.

102
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Figure 3.1. Oxidation of [1-14C]C16:0 to CO2 or acid-soluble products (ASP) after
pretreatment with C16:0 and C18:3n-3 cis. Oxidation by Madin-Darby bovine kidney
(MDBK) cells was measured over a 3 h period after 21 h pretreatments with BSA-bound
fatty acids (FA). Fatty acid pretreatments were either single fatty acids (C16:0 or C18:3n3 cis) or combinations of C16:0 with C18:3n-3 cis in the molar ratios listed. All
treatments totaled 1.0 mM in Dulbecco’s Modified Eagle’s Medium (DMEM) with 1%
BSA. Control is DMEM with 1% BSA and no additional FA. Data are reported as least
squares means with associated standard errors. Within substrate fraction, CO2 or ASP,
means without a common superscript differ (P < 0.05).
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Figure 3.2. Oxidation of [1-14C]C16:0 to CO2 or acid-soluble products (ASP) after
pretreatment with C18:0 and C18:3n-3 cis. Oxidation by Madin-Darby bovine kidney
(MDBK) cells was measured over a 3 h period after 21 h pretreatments with BSA-bound
fatty acids (FA). Fatty acid pretreatments were either single fatty acids (C18:0 or C18:3n3 cis) or combinations of C18:0 with C18:3n-3 cis in the molar ratios listed. All
treatments totaled 1.0 mM in Dulbecco’s Modified Eagle’s Medium (DMEM) with 1%
BSA. Control is DMEM with 1% BSA and no additional FA. Data are reported as least
squares means with associated standard errors. Within substrate fraction, CO2 or ASP,
means without a common superscript differ (P < 0.05).
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Figure 3.3. Oxidation of [1-14C]C16:0 to CO2 or acid-soluble products (ASP) after
pretreatment with C18:1n-9 cis and C18:3n-3 cis. Oxidation by Madin-Darby bovine
kidney (MDBK) cells was measured over a 3 h period after 21 h pretreatments with BSAbound fatty acids (FA). Fatty acid pretreatments were either single fatty acids (C18:1n-9
cis or C18:3n-3 cis) or combinations of C18:1n-9 cis with C18:3n-3 cis in the molar
ratios listed. All treatments totaled 1.0 mM in Dulbecco’s Modified Eagle’s Medium
(DMEM) with 1% BSA. Control is DMEM with 1% BSA and no additional FA. Data are
reported as least squares means with associated standard errors. Within substrate fraction,
CO2 or ASP, means without a common superscript differ (P < 0.05).
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Figure 3.4. Relationship between pyruvate carboxylase (PC) mRNA expression and rate
of C16:0 metabolism to CO2 or acid-soluble products (ASP), including ketones. MDBK
cells at 80% confluence were cultured with BSA-bound fatty acids (FA) for 24 h (mRNA
expression) or 21 h (substrate oxidation). Fatty acid treatments were combinations of
fatty acids in 10:90, 25:75, 50:50, or 75:25 molar ratios from combinations of C16:0:
C18:3n-3 cis, and in 25:75, 50:50, 75:25, or 90:10 molar ratios from combinations of
C18:0: C18:3n-3 cis, or C18:1n-9 cis: C18:3n-3 cis. All treatments totaled 1.0 mM in
Dulbecco’s Modified Eagle’s Medium (DMEM) with 1% BSA. Data are reported as least
squares means with associated standard errors. Means without a common superscript
differ (P < 0.05). Pearson correlation coefficients for PC mRNA expression and nmol 14C
substrate conversion to either 14CO2 or ASP (per μg DNA-1 • h-1) are shown.
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Figure 3.5. Relationship between cytosolic phosphoenolpyruvate carboxykinase (PCK1)
mRNA expression and rate of C16:0 metabolism to CO2 or acid-soluble products (ASP),
including ketones. MDBK cells at 80% confluence were cultured with BSA-bound fatty
acids (FA) for 24 h (mRNA expression) or 21 h (substrate oxidation). Fatty acid
treatments were combinations of fatty acids in 10:90, 25:75, 50:50, or 75:25 molar ratios
from combinations of C16:0: C18:3n-3 cis, and in 25:75, 50:50, 75:25, or 90:10 molar
ratios from combinations of C18:0: C18:3n-3 cis, or C18:1n-9 cis: C18:3n-3 cis. All
treatments totaled 1.0 mM in Dulbecco’s Modified Eagle’s Medium (DMEM) with 1%
BSA. Data are reported as least squares means with associated standard errors. Means
without a common superscript differ (P < 0.05). Pearson correlation coefficients for
PCK1 mRNA expression and nmol 14C substrate conversion to either 14CO2 or ASP (per
μg DNA-1 • h-1) are shown.
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CHAPTER 4. PYRUVATE CARBOXYLASE PROXIMAL PROMOTER
ACTIVITY IS REGULATED BY SATURATED AND UNSATURATED
FATTY ACIDS IN MADIN-DARBY BOVINE KIDNEY CELLS

ABSTRACT

An increase in bovine pyruvate carboxylase (PC; EC 6.4.1.1) at calving and
during feed restriction corresponds with increased circulating nonesterified fatty acids
(NEFA) as a consequence of negative energy balance. Regulation of PC mRNA and
impact of saturated and unsaturated fatty acid profile has not yet to be explored. Our
objective was to determine effects of chain length, degree of saturation and copresence of
saturated and unsaturated fatty acids on activity of bovine PC promoter 1 (PCP1). For
these experiments MDBK cells were transfected with a full length bovine PCP1 construct
from -1002 to +3 bp relative to the bovine PC gene transcription start site (bovine PCP1(1002_+3))

ligated to a Firefly luciferase reporter, or with one of a series of nested 5’ serial

truncations (bovine PCP1(-773_+3), bovine PCP1(-494_+3), or bovine PCP1(-222_+3)). Cells
were exposed for 23 h to either individual fatty acids bound to BSA (C16:0, C18:0, or
C18:3n-3 cis) or to fatty acid mixtures in ratios of 75:25, 50:50, or 25:75 corresponding
to combinations of C16:0: C18:3n-3 cis or C18:0: C18:3n-3 cis. Total fatty acid
concentration was 1.00 mM. Exposure to either C16:0 or C18:3n-3 cis alone elicited a
significant (P < 0.05) increase in bovine PCP1(-1002_+3) activity compared to 1% BSA

109
DMEM control treatment (33.97, 50.05, and 19.64 ± 6.15 Fold of promoter induction
(AU) for C16:0, C18:3n-3 cis, and control, respectively). Treatment with C18:3n-3 cis
alone caused a greater increase (P < 0.05) in promoter activity compared to C16:0 alone,
indicating a lesser response to C16:0 alone. Interestingly, inclusion of C18:3n-3 cis, at
any level in fatty acid ratios examined, increased promoter activity of bovine PCP1(773_+3)

or bovine PCP1(-222_+3) compared to activity of bovine PCP1(-1002_+3). Data from the

bovine PCP1 truncation and fatty acid copresence experiments reveal the potential for
response elements of unsaturated fatty acids or fatty acid ligands in several bovine PCP1
promoter regions. In silico analysis of bovine PCP1 identified putative peroxisome
proliferator-activated receptor (PPAR) α and sterol regulatory element binding protein
(SREBP) binding sites which may be implicated in fatty acid signaling to alter bovine
PCP1 activity. Pyruvate carboxylase promoter 1 activity that is mediated by unsaturated
fatty acids acting through elements within -1002 and -222 of bovine PCPI, may
determine PC response during periods of negative energy balance in dairy cows.

Keywords: bovine, fatty acid, pyruvate carboxylase proximal promoter
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INTRODUCTION

Pyruvate carboxylase (PC; EC 6.4.1.1) plays a central role in the anaplerotic
supply of oxaloacetate (OAA) for the tricarboxylic acid (TCA) cycle and the cataplerotic
supply of carbons for gluconeogenesis. Expression of PC mRNA is significantly elevated
in dairy cows around the time of calving and during feed restriction, and has been linked
to increased fatty acid concentrations (Greenfield et al., 2000; Velez and Donkin, 2005;
White et al., 2011a,b). Diets fed during the prepartum interval alter both the
concentration and profile of plasma fatty acids in dairy cows at calving (Rukkwamsuk et
al., 2000; Douglas et al., 2007; Petit et al., 2007). Likewise, changes in PC mRNA during
feed restriction are linked to changes in serum fatty acid concentrations and profiles
(White et al., 2011b) and these effects are mediated through promoter 1 and located
proximal to the transcription start site (PCP1) of the bovine PC gene. However, there
appears to be opposing effects of saturated fatty acids on PC promoter activity (White et
al., 2011b,c).
Regulation of PC gene expression by fatty acids has been characterized in several
species and appears to be linked through peroxisome proliferator-activated receptors
(PPAR; Jitrapakdee et al., 2008). The contrasting effects of unsaturated fatty acids and
saturated fatty acids that serve as PPAR agonists and antagonists for bovine PC may be a
consequence of differences in modes of signaling for these fatty acids and cross talk that
involve sterol regulatory element binding protein (SREBP)-1c and liver X receptor
(LXR; Yoshikawa et al., 2003). Direct effects of saturated and unsaturated fatty acids and
the interplay between these fatty acids on bovine PCP1 have not been fully elucidated.
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Based on previous data indicating opposing effects of C18:0 and C18:3n-3 cis on bovine
PC mRNA, we hypothesized that fatty acid profile, and specifically the ratio of saturated
to unsaturated fatty acids, regulates the activity of bovine PCP1. Our objective was to
determine the effects of fatty acid chain length and degree of saturation and the
copresence of saturated and unsaturated fatty acids on the activity of bovine PCP1.
Madin-Darby bovine kidney (MDBK) cells were utilized in the current study. Previous
research on enzymes associated with gluconeogenic pathways in MDBK cells (Bionaz et
al., 2008a,b; Thering et al., 2009; White et al., 2012), and examination of the
transcriptomes of MDBK cells compared to bovine liver (Bionaz et al., 2008b) support
the use of this cell model system.

MATERIALS AND METHODS

Cell Culture
Madin-Darby bovine kidney epithelial cells (NBL-1 ATCC CCL-22) were
obtained at passage 110 from the American Type Culture Collection (ATCC, Manassas,
VA). Cells were propagated in sterile polystyrene 150-cm2 canted-neck, 0.2 µm vent cap
flasks (Corning, Corning, NY) in Dulbecco’s Modified Eagle medium (DMEM)
containing 1 g/L D-glucose, L-glutamine, and 110 mg/L sodium pyruvate (Life
Technologies, Grand Island, NY) supplemented with 10% fetal bovine serum (FBS;
Sigma-Aldrich Corp., St. Louis, MO), 10 mg/L piperacillin (Sigma-Aldrich Corp.), and
10 mg/L ciprofloxacin (Sigma-Aldrich Corp.), at 37°C in 5% CO2 and 95% air. Media
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was refreshed every two to three d. Cells were subcultured to near confluence following
media removal with trypsin-EDTA (Sigma-Aldrich Corp., St. Louis, MO). Trypsin
activity was inhibited by addition of 10 mL of fresh DMEM supplemented with 10% FBS
(Sigma-Aldrich Corp.), 10mg/L piperacillin and 10mg/L ciprofloxacin. For each
experimental replicate, cells were plated on 24-well plates (Corning, Glendale, AZ) at a
density of 1.5 × 105 cells per 15.6-mm diameter well and incubated in 10% FBS DMEM
with antibiotics, as indicated above, to achieve approximately 80% confluence before
exposure to treatments.

Promoter Constructs and DNA Transfections
To test the effects of fatty acids on bovine PCP1 activity, cells were transfected
with one of four possible promoter-luciferase constructs containing segments of bovine
PCP1 truncated from the 5' end of the bovine PC gene and linked to a reporter gene for
firefly luciferase. The full length construct for bovine PCP1 contained bases 613,522
through 612,518 of bovine chromosome 29 (GenBank accession NW_00149451.1),
which corresponds to the region from −1,001 through +3 bp relative to the transcription
start site of bovine PCP1 (Hazelton et al., 2008). The ligated pGL3 constructs were as
previously described (White et al., 2011c), including the full length construct of bovine
PCP1 (PCP1(-1002_+3)), and truncations consisting of -773 through +3 bp (bovine PCP1(773_+3)),
222_+3))

-494 through +3 bp (bovine PCP1(-494_+3)), and -222 through +3 bp (bovine PCP1(relative to the transcription start site, respectively.
The pGL3 family of plasmids (Promega, Madison, WI) was utilized for the

current experiments. The pGL3-Basic plasmid, lacking a promoter sequence, was used as
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a negative control for transfection experiments. A luciferase reporter plasmid containing
the SV40 promoter, pGL3-SV40, served as a positive control. Co-transfection of cells
with a Renilla luciferase plasmid, pRL-CMV (Promega), provided a normalization
control for transfection efficiency.
Transient transfections in MDBK cells were performed using Lipofectamine 2000
(Invitrogen Inc., Waltham, MA) according to the manufacturer’s instructions. For
transfection, cells were incubated in media containing 1% BSA (Probumin; Millipore,
Billerica, MA) without antibiotics. A volume of 100 µL of the Lipofectamine-plasmid
mixture containing 98 µL of Opti-MEM I Reduced Serum Medium (Life Technologies
Inc., Grand Island, NY), 2 µL of Lipofectamine, 0.8 µg of each tested plasmid and 0.008
µg of a Renilla pRL-CMV luciferase plasmid was added to each well. Five hours after
transfection, media was removed by aspiration, and replaced with the treatment additions
to DMEM containing 1% BSA and without antibiotics. Basal promoter activity and
responsiveness to presence of single fatty acids or their combinations were tested during
a 23 h treatment interval.

Treatments
Fatty acids C16:0, C18:0, C18:3n-3 cis (Sigma-Aldrich Corp.) were bound to
BSA (Probumin; Millipore, Billerica, MA) in a 4:1 molar ratio as described previously
(Berry et al., 1991). Cells at 80% confluence were cultured in DMEM and exposed for 23
h to either 1% BSA (no addition control), or to 1.0 mM individual fatty acid (bound to
BSA), or to combinations of fatty acids in 25:75, 50:50, or 75:25 molar ratios from
combinations of C16:0: C18:3n-3 cis or C18:0: C18:3n-3 cis. Total fatty acid
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concentration in each combination was 1.0 mM and total BSA concentration was 1%.
Treatments were applied in triplicate to three cell replicates.

Luciferase Activity
Following 23 h exposure to treatments, media was removed by aspiration and
cells were rinsed with ice-cold 1x PBS and harvested in 80 µL 1 × passive lysis buffer
(Promega, Madison, WI). Cells were removed to a 0.65 mL microcentrifuge tube and
stored at -20°C until further processing. Luciferase activity in 20 μL of cell lysates was
initiated by the addition of 100 μL of firefly luciferase detection reagent followed by
addition of 100 μL of Renilla luciferase detection agent (Promega, Madison, WI).
Luminescence was quantified using a Tecan GENios Pro spectrofluorometer with
Magellan 5.0 software (Tecan, Research Triangle Park, NC). Data were normalized for
transfection efficiency by dividing the relative light units detected for firefly luciferase by
the corresponding Renilla luciferase relative light units (firefly: Renilla) for each well.
Activity of bovine PCP1 or bovine PCP1 truncations for each treatment was normalized
to expression of PGL3-basic. All experiments were repeated in triplicate to three separate
cell preparations.

Statistical Analysis
Data were analyzed for normality or error variances using the Univariate
procedure of SAS 9.3 (SAS Institute Inc., Cary, NC). Analyses of variance was
performed using the Proc Mixed procedure of SAS. The model accounted for the fixed
effects of treatment and the random effects of cell replicate. Means were considered

115
different when P < 0.05 and tended to differ if 0.05 ≤ P ≤ 0.10. Tukey-Kramer
studentized adjustments were used to separate treatment means. Data are reported as least
squares means with associated standard errors.

In Silico Promoter Sequence Analysis
Bovine PCP1 sequence (-1002/+3) was analyzed using the PROMO virtual
laboratory of ALGGEN, which utilizes TRANSFAC version 8.3 (Messeguer et al., 2002;
Farré et al., 2003). The search parameters were limited to liver specific factors, highquality matrices, and set to minimize false positives.

RESULTS AND DISCUSSION

The MDBK cell line is utilized in the current study to examine the effects of
saturated and unsaturated fatty acids on the activity of bovine PCP1. Previous research
supports the use of the MDBK cell model through similarities between transcriptomes of
the cell line and liver samples from periparturient dairy cows and responsiveness to fatty
acids (Bionaz et al., 2008a,b; Thering et al., 2009; White et al., 2012).
Bovine PC contains three promoters which give rise to six 5’ UTR variants (Agca
et al., 2004; Hazelton et al., 2008). Development of a novel quantitative real-time RTPCR multiplex assay confirmed the correlation between transcript abundance and
transcription rate for bovine 5’ UTR variants (White et al., 2011a). Fatty acid treatments
created to mimic circulating nonesterified fatty acid (NEFA) profiles around calving or
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during induced fatty liver increased expression of PC 5’ UTR variant products of bovine
PCP1 in MDBK cells (White et al., 2012). This response was not seen after treatment
with fatty acid profiles representing the pre- or postpartum period, nor was a response
seen in 5’UTR variants of PCP2 or PCP3 (White et al., 2012).
The current study utilized the pGL3-luciferase family of promoter constructs. The
negative control was the promoterless parent vector, pGL3-Basic and the pGL3-SV40
Promoter served as the positive control. The positive control pGL3-SV40 Promoter drove
luciferase expression by almost 4 fold relative to pGL3-Basic (P < 0.05; Figure 4.1).
Bovine PCP1(-1002_+3), as well as any of the examined 5’ bovine PCP1 truncations, were
able to drive luciferase expression at least 1.5 fold compared to the pGL3-Basic
promoterless negative control (P < 0.05; Figure 4.1). Bovine PCP1(-773_+3) and bovine
PCP1(-222_+3)-coupled expression did not differ (P > 0.10) from pGL3-SV40 Promoterdriven luciferase expression (Figure 4.1). Bovine PCP1(-494_+3) drove luciferase
expression and did not differ (P > 0.10) from bovine PCP1(-1002_+3)-coupled luciferase
expression.
To examine the effects of single fatty acids on bovine PCP1(-1002_+3) activity,
MDBK cells transfected with bovine PCP1(-1002_+3) were exposed for 23 h to either 1%
BSA DMEM, or to 1.0 mM C16:0, C18:0, or C18:3n-3 cis. Response in promoter activity
was normalized to activity of pGL3-Basic promoterless vector (Figure 4.2). Cells
exposed to either C16:0 or C18:3n-3 cis alone elicited a significant (P < 0.05) increase in
bovine PCP1(-1002_+3) activity (Figure 4.2). Treatment with C18:3n-3 cis alone caused a
significantly greater increase (P < 0.05) in promoter activity compared to C16:0 alone,
indicating a greater magnitude of response to C18:3n-3 cis alone (Figure 4.2).
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Bovine PCP1 was further evaluated to determine the effects of fatty acid
treatments on activity of bovine PCP1 5’ serial truncations. Compared to bovine PCP1(1002_+3),

bovine PCP1(-773_+3) exhibited significantly greater (P < 0.05) activity relative to

control incubations in 1% BSA DMEM, or after exposure to 1.0 mM C18:3n-3 cis
(Figure 4.2). Bovine PCP1(-494_+3) showed a decreased (P < 0.05) response to C18:3n-3
cis compared to bovine PCP1(-1002_+3), and response of bovine PCP1(-494_+3) to other single
fatty acids or control did not differ from bovine PCP1(-1002_+3) response. In contrast,
bovine PCP1(-222_+3) exhibited increased (P < 0.05) activity, compared to bovine PCP1(1002_+3),

after exposure to control 1% BSA DMEM, C16:0, C18:0, or C18:3n-3 cis (Figure

4.2). Results presented here indicate potential for C18:3n-3 cis-induced response in
bovine PCP1(-1002_+3), bovine PCP1(-773_+3), and bovine PCP1(-222_+3) truncation regions,
and the potential for C16:0 or C18:0-induced response in bovine PCP1(-222_+3).
Previously, expression of bovine PCP1 showed a linear decrease in response to
increasing concentrations (from 0.25 to 1.0 mM) of C18:0 when bovine PCP1 truncations
were transfected into H4IIE rat hepatoma cells (White et al., 2011c). Results from
previous studies demonstrate that the activity of bovine PCP1 is repressed after exposure
to 1.0 mM C18:0, regardless of the bovine PCP1 truncation, indicating a C18:0responsive region in within the bovine PCP1(-222_+3) (White et al., 2011c), which is in
agreement with current findings. When compared to PC mRNA expression data in
response to these same fatty acid treatment ratios (CHAPTER 2), the bovine PCP1
activity data presented in the current study do not parallel the repression caused by
saturated fatty acids compared to control treatments. Because such dramatic changes are
seen in mRNA expression, without similar patterns in promoter activity, this suggests that
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other factors, such as mRNA degradation or stability, are influenced by the presence of
saturated fatty acids and independent experiments are necessary to confirm these effects.
Activity of bovine PCP1 was significantly increased with exposure to serum from
feed-restricted, compared to control, cows when bovine PCP1(-1002_+3) was transfected
into the H4IIE rat hepatoma cell line (White et al., 2011b). Taken together with previous
data showing an increase in PC mRNA during feed restriction in dairy cows (Velez and
Donkin, 2005), and that bovine PC enzyme activity is directly correlated with PC mRNA
expression (Greenfield et al., 2000), the potential influence of circulating factors in the
serum from feed-restricted cows on PC activity emerges. Modifying the serum from
control cows to contain increased concentrations of fatty acids, in proportion to their
presence in serum from feed-restricted cows, elicited an increase in bovine PCP1 activity
compared with exposure to serum from feed-restricted cows (White et al., 2011b). Data
reported in the current study supports the regulation of bovine PCP1 by fatty acids and
extends these observations to the direct influence of C16:0, C18:0, and C18:3n-3 on
bovine PCP1 activity.
During the transition period, or the 6-wk period surrounding calving in dairy
cows, the predominate plasma NEFA profile consists mainly of C16:0, C18:0, and C18:1
fatty acids (Rukkwamsuk et al., 1999). During this time, C18:0 plasma levels increase
while C18:1 levels are similar pre- or postpartum (Rukkwamsuk et al., 1999; Douglas et
al., 2007). Levels of C16:0 and C18:1 increase in liver of dairy cows that have been
induced with fatty liver, compared to control animals, mainly due to release of these fatty
acids from adipose tissue lipolysis (Rukkwamsuk et al., 2000). The fatty concentrations
in the current experiment (1.0 mM) are similar in magnitude to total circulating NEFA
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levels at parturition in dairy cows (Rukkwamsuk et al., 1999). Although treatments with a
single fatty acid are not realistic in a physiological setting, previous research that has
examined the effect of serum from control and feed restricted cows on bovine PCP1
activity (White et al., 2011b) indicates induction of PC, but the role of specific fatty acids
in this regard was unclear. Data from the current study indicates that the increase in PC
mRNA is associated with location-specific promoter activation of bovine PCP1 by
C18:3n-3 cis.
To further examine the interplay for saturated or unsaturated fatty acids on PC
gene expression, and to more closely mimic physiological fatty acid profiles, the effects
of treatment combinations of saturated and unsaturated fatty acids were interrogated
using nested 5’ deletions of bovine PCP1. Treatment with 0.75:0.25, 0.50:0.50, or
0.25:0.75 C16:0: C18:3n-3 cis increased (P < 0.05) activity of bovine PCP1(-773_+3),
compared to activity of bovine PCP1(-1002_+3) (Figure 4.3). Similarly, treatment with
0.75:0.25, 0.50:0.50, or 0.25:0.75 C16:0: C18:3n-3 cis increased (P < 0.05) activity of
bovine PCP1(-222_+3), compared to activity of bovine PCP1(-1002_+3) (Figure 4.3). Similar to
treatment with C18:3n-3 cis alone, treatments of 0.50:0.50 or 0.25:0.75 C16:0: C18:3n-3
cis elicited a significant (P < 0.05) decrease in truncated promoter activity compared to
activity of bovine PCP1(-1002_+3) within each treatment (Figure 4.3). Activity of bovine
PCP1(-494_+3) decreased (P < 0.05), compared to bovine PCP1(-1002_+3) activity after
exposure to 0.50:0.50, or 0.25:0.75 C16:0: C18:3n-3 cis (Figure 4.3). Similar response
patterns were seen over all bovine PCP1 truncations with treatment combinations of
C18:0: C18:3n-3 cis (Figure 4.4). These data again point to both activating and
suppressive influences of fatty acids on different bovine PCP1 regions. Because response

120
to inclusion, at any level, of C18:3n-3 cis increased promoter activity of bovine PCP1(773_+3)

or bovine PCP1(-222_+3) compared to activity of bovine PCP1(-1002_+3), these data

support the potential for response elements of unsaturated fatty acids or fatty acid ligands
in this region.
Transcriptional regulation of genes by long chain fatty acids occurs through a
complement of transcription factors, including PPARα, hepatocyte nuclear factor
(HNF)4, and LXR (Pawar and Jump, 2003; Jump, 2013). Because primary regulators of
these transcription factors include C18- and C20-carbon fatty acids (Jump, 2013),
changes in the circulating NEFA profile concurrent with feed restriction or during
parturition in dairy cows are of particular interest.
Ligands capable of binding to PPAR include fatty acids, peroxisome proliferators,
antidiabetic, and hypolipidemic drugs (Schoonjans et al., 1996). Activated, ligand-bound
PPAR forms a heterodimer with retinoid X receptor before biding to response elements.
In liver, the predominant form is PPARα, which is linked to both fatty acid β-oxidation
and lipid metabolism (Lee et al., 1995). Bovine hepatocyte isolations from 7-wk-old
calves given treatment of a PPARα agonist for 5 d showed increased conversion of C16:0
to CO2 compared to control (Litherland et al., 2010). The activity of bovine PCP1 is
upregulated through PPARα agonists, and suppressed by C18:0 in rat hepatoma cells
transfected with bovine PCP1 (White et al., 2011c). Furthermore, responsiveness of
bovine PCP1 is regulated by serum fatty acid profiles that are altered during feed
restriction and negative energy balance (White et al., 2011b), but the dominance of
control of saturated and unsaturated fatty acids, and the concentration required to elicit a
response have not yet been defined.
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Sterol regulatory element-binding proteins are a family of transcription factors
intricately involved in both lipogenesis and cholesterol synthesis. The predominant
isoform in liver, SREBP-1c, is increased during over nutrition or with increased
circulating glucose concentrations in rodents (Horton et al., 1998), and is downregulated
by polyunsaturated fatty acids (Shimano, 2009). Recently, SREBP-1c mediated signaling
has been implicated in postprandial increase in C18:0 associated with insulin resistance in
diabetic humans and rats (Chu et al., 2013). Liver X receptors are activated by oxysterols
and also activate the expression of SREBP-1c (Yoshikawa et al., 2001). This link
between cholesterol metabolism and fatty acid metabolism has been further solidified as
PPARα and PPARα agonists have been shown to reduce the binding LXR to LXR
response elements in the SREBP-1c promoter by reducing LXR dimerization to retinoid
X receptor (Yoshikawa et al., 2003). This crosstalk between PPARα and LXR to limit
SREBP-1c supports the potential for interplay between saturated and unsaturated fatty
acids to influence gene expression and subsequent cellular lipid metabolism.
In silico analysis of the bovine PCP1 using the PROMO virtual laboratory of
ALGGEN, which utilizes TRANSFAC version 8.3 (Messeguer et al., 2002; Farré et al.,
2003), revealed several putative binding sites for both PPARα and SREBP (Figure 4.5).
Putative PPARα binding sites are identified at -989 to -933, -401 to -395, and from -73 to
-67 bp relative to bovine PCP1(-1002_+3) transcription start site (TSS; Figure 4.5). Putative
SREBP sites are identified at -411 to -397 bp relative to bovine PCP1(-1002_+3) TSS for
SREBP-1 and at -665 to -654 and -408 to -398 bp relative to bovine PCP1(-1002_+3) TSS
for SREBP-2 (Figure 4.5). Finally, a putative LXR site is identified at -74 to -68 bp
relative to bovine PCP1(-1002_+3) TSS (Figure 4.5). Abbreviations for additional putative
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transcription factors identified in Figure 4.5 are listed in Table 4.1. Promoter truncation
activity in response to fatty acids treatments supports the potential for activation by the
presence of C18:3n-3 cis of bovine PCP1(-1002_+3), and bovine PCP1(-222_+3); regions which
contain a putative PPARα binding site. The lack of response to C18:3n-3 cis inclusion for
bovine PCP1(-494_+3) may be attributed to the presence of putative SREBP-1 and SREBP-2
sites, or the potential for crosstalk between these transcription factors and their binding
sites. This hypothesis is further supported by the upregulation of bovine PCP1 through
PPARα agonists, and suppression by C18:0 in transfected rat hepatoma cells (White et
al., 2011c), and by the potential for crosstalk between PPARα and LXR to reduce
SREBP-1c-induced signaling (Yoshikawa et al., 2003). Taken together, the data reported
in the current study support the involvement of both PAPRα and SREBP as the
underlying signaling pathways mediating the expression of bovine PCP1.
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CONCLUSIONS
Data presented here indicates several potential fatty acid-responsive regions of
bovine PCP1. Specifically, that increased activity of bovine PCP1(-1002_+3), and bovine
PCP1(-222_+3) in response to inclusion of C18:3n-3 cis may be due to potential signaling
through putative PPARα binding sites identified in these regions. Furthermore, repression
of bovine PC may be linked to putative SREBP binding sites within region -494 through
+3 of bovine PCP1. Additional research is necessary to confirm involvement of these
transcription factors in regulating bovine PC expression and to determine the precise
mechanisms by which fatty acids interact to regulate bovine PCP1 activity.
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Figure 4.1. Basal promoter activity of bovine pyruvate carboxylase promoter 1 (PCP1)
and bovine PCP1 regions serially truncated from the 5' end. The longest construct, bovine
PCP1(-1002_+3), and serial 5' truncations, bovine PCP1(-773_+3), bovine PCP1(-494_+3), and
bovine PCP1(-222_+3), were individually ligated to Firefly luciferase reporter and
transefected in Madin-Darby bovine kidney (MDBK) cells. Cotransfection of Renilla
pRL-CMV luciferase plasmid was used to normalize transfection efficiency. Five hours
after transfection, cells were incubated in DMEM containing 1% BSA without antibiotics
for 23 h and luciferase activities were then determined in cell lysates. The pGL3-Basic is
promoterless and used as a negative control, and the pGL3-SV40 Promoter served as
positive control. Promoter activity is expressed as ratio of Firefly luciferase to Renilla
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luciferase. Data are reported as least squares means with associated standard errors.
Means without a common superscript differ (P < 0.05).
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Figure 4.2. Effect of 23 h single fatty acid treatments, C16:0, C18:0, or C18:3n-3 cis, on
induction of bovine pyruvate carboxylase promoter 1 (PCP1) and bovine PCP1 regions
serially truncated from the 5’ end in Madin-Darby bovine kidney (MDBK) cells. The
longest construct, bovine PCP1(-1002_+3), and serial 5' truncations, bovine PCP1(-773_+3),
bovine PCP1(-494_+3), and bovine PCP1(-222_+3), were individually ligated to Firefly
luciferase reporter and transfected into MDBK cells. Cotransfection of Renilla pRL-
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CMV luciferase plasmid was used to normalize transfection efficiency. Five hours after
transfection, cells were exposed to single fatty acid treatments (C16:0, C18:0, or C18:3n3 cis). All treatments totaled 1.0 mM in Dulbecco’s Modified Eagle’s Medium (DMEM)
with 1% BSA. Control treatment is DMEM with 1% BSA and no additional fatty acid.
Promoter activity is expressed as ratio of Firefly luciferase to Renilla luciferase,
normalized to pGL3-Basic promoterless negative control basal expression. Data are
reported as least squares means with associated standard errors. Within treatment,
asterisk indicates a significant (P < 0.05) difference from bovine PCP1(-1002_+3). Within
bovine PCP1 truncation, means without a common superscript differ (P < 0.05).
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Figure 4.3. Effect of 23 h C16:0: C18:3n-3 cis fatty acid treatments on induction of
bovine pyruvate carboxylase promoter 1 (PCP1) and bovine PCP1 regions serially
truncated from the 5’ end in Madin-Darby bovine kidney (MDBK) cells. The longest
construct, bovine PCP1(-1002_+3), and serial 5' truncations, bovine PCP1(-773_+3), bovine
PCP1(-494_+3), and bovine PCP1(-222_+3), were individually ligated to Firefly luciferase
reporter and transfected into MDBK cells. Cotransfection of Renilla pRL-CMV
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luciferase plasmid was used to normalize transfection efficiency. Five hours after
transfection, cells were exposed to fatty acid combinations in 25:75, 50:50, or 75:25
ratios for the fatty acid combinations of C16:0: C18:3n-3 cis. All treatments totaled 1.0
mM in Dulbecco’s Modified Eagle’s Medium (DMEM) with 1% BSA. Control treatment
is DMEM with 1% BSA and no additional fatty acid. Promoter activity is expressed as
ratio of Firefly luciferase to Renilla luciferase, normalized to pGL3-Basic promoterless
negative control basal expression. Data are reported as least squares means with
associated standard errors. Within treatment, asterisk indicates a significant (P < 0.05)
difference from bovine PCP1(-1002_+3). Within bovine PCP1 truncation, means without a
common superscript differ (P < 0.05).
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Figure 4.4. Effect of 23 h C18:0: C18:3n-3 cis fatty acid treatments on induction of
bovine pyruvate carboxylase promoter 1 (PCP1) and bovine PCP1 regions serially
truncated from the 5’ end in Madin-Darby bovine kidney (MDBK) cells. The longest
construct, bovine PCP1(-1002_+3), and serial 5' truncations, bovine PCP1(-773_+3), bovine
PCP1(-494_+3), and bovine PCP1(-222_+3), were individually ligated to Firefly luciferase
reporter and transfected into MDBK cells. Cotransfection of Renilla pRL-CMV
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luciferase plasmid was used to normalize transfection efficiency. Five hours after
transfection, cells were exposed to fatty acid combinations in 25:75, 50:50, or 75:25
ratios for the fatty acid combinations of C18:0: C18:3n-3 cis. All treatments totaled 1.0
mM in Dulbecco’s Modified Eagle’s Medium (DMEM) with 1% BSA. Control treatment
is DMEM with 1% BSA and no additional fatty acid. Promoter activity is expressed as
ratio of Firefly luciferase to Renilla luciferase, normalized to pGL3-Basic promoterless
negative control basal expression. Data are reported as least squares means with
associated standard errors. Within treatment, asterisk indicates a significant (P < 0.05)
difference from bovine PCP1(-1002_+3). Within bovine PCP1 truncation, means without a
common superscript differ (P < 0.05).
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Figure 4.5. A diagram of bovine pyruvate carboxylase promoter 1 (PCP1; -1002/+3 bp
relative to transcription start site) and putative transcription factor binding sites. Putative
transcription factor binding sites were identified using the PROMO virtual laboratory of
ALGGEN, which utilizes TRANSFAC version 8.3 (Messeguer et al., 2002; Farré et al.,
2003). The search parameters were limited to liver specific factors, high-quality matrices,
and set to minimize false positives. Abbreviations for common transcription factors are
listed in Table 4.1.
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Table 4.1. Abbreviations for common transcription factors whose putative binding sites
are identified in bovine pyruvate carboxylase promoter 1. Putatuve transcription factors
were identified using the PROMO virtual laboratory of ALGGEN, which utilizes
TRANSFAC version 8.3 (Messeguer et al., 2002; Farré et al., 2003).
Abbreviation

Common name

ATF

Activating transcription factor

ATF-4

Activating transcription factor 4

CAR

Constitutive androstane receptor

C-Jun

Jun proto-oncogene

COUP

Chicken ovalbumin upstream transcription factor

CREB

cAMP responsive element binding protein

Ebox

Viral oncogene homolog

FXR

Farnesoid X receptor

GR

Glucocorticoid receptor

HNF1α

Hepatocyte nuclear factor-1α

HNF1β

Hepatocyte nuclear factor-1β

LRH1

Liver receptor homologous protein

LXR

Liver X receptor

p50

p50; nuclear factor κB light chain gene enhancer

p65

p65; nuclear factor κB light chain gene enhancer

PPARα

Peroxisome proliferator-activated receptor α

PXR

Pregnane X receptor

RAR

Retinoic acid receptor

RXR

Retinoid X receptor

SREBP1

Sterol regulatory element binding protein 1

SREBP2

Sterol regulatory element binding protein 2

USF

Upstream specificity factor

USF1

Upstream specificity factor 1

USF2

Upstream specificity factor 2
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CHAPTER 5. CONCLUSIONS AND IMPLICATIONS

Pyruvate carboxylase (PC) is responsible for the synthesis of oxaloacetate (OAA)
from pyruvate, a reaction critical to both the anaplerotic push and cataplerotic pull of
carbons through the tricarboxylic acid (TCA) cycle. The pool of available OAA appears
to be critical in determining the oxidative capacity of the cell and the maintenance of this
pool is a function of the balance of anaplerotic and cataplerotic processes in the cell. If
the pull of carbons to gluconeogenesis, namely through actions of the enzyme
phosphoenolpyruvate carboxykinase (PCK), is less than the supply of carbons to the TCA
cycle by PC, then the oxidative capacity of the cell should be increased, yielding
increased oxidation of acetyl-CoA. The study of factors, including fatty acids, which
influence PC activity and subsequent OAA supply is necessary for a better understanding
of the relationship between carbohydrate and lipid metabolism. The central hypothesis of
this dissertation is that the ratio of the most prevalent circulating nonesterified saturated
and unsaturated fatty acids in dairy cows regulates PC flux and subsequent fatty acid
metabolism. The objectives of this dissertation were to determine: 1) the response of PC
mRNA to the copresence of the most abundant saturated and unsaturated fatty acids
present in circulation in periparturient dairy cows; 2) the direct effects of these saturated
and unsaturated fatty acids, and their combinations, on the cellular oxidation of fatty
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acids, and the potential relationship to PC; 3) the effects of the copresence of these
saturated and unsaturated fatty acids on the transcriptional activity of bovine PC proximal
promoter (PCP1).
Characterization of PC response to the copresence of saturated and unsaturated
fatty acids was tested in a bovine kidney cell line and in bovine primary hepatocytes. The
fatty acids tested included C16:0, C18:0, C18:1n-9 cis, and C18:3n-3 cis, as these are the
predominant circulating fatty acids in periparturient dairy cows. There is a significant
depression of PC mRNA expression after exposure to either C16:0 or C18:0 alone in
bovine kidney cells; this depression is ameliorated by inclusion of C18:3n-3 cis in the
kidney cell model. Monounsaturated C18:1n-9 cis did not elicit a change in PC mRNA
expression, indicating that degree of fatty acid saturation is key for influence on PC.
Bovine primary hepatocytes displayed a similar, though not significantly different,
numerical pattern in response to fatty acid treatments. In contrast to data from bovine
kidney cells, PC expression increased nearly two-fold with exposure to C18:3n-3 cis
alone in primary hepatocytes. This discrepancy may reflect differences in sensitivity to
fatty acid exposure between cell types, cell or in vivo conditions prior to initiation of the
experiments, or both.
To determine if changes in PC mRNA expression were related to oxidative
capacity of cell, substrate flux was determined following exposure to the copresence of
saturated and unsaturated fatty acids. Fatty acid flux to CO2 was correlated to PC mRNA
expression, while fatty acid substrate flux to ketone body production, representing
incomplete oxidation, was less evident but still tended to correlate with PC mRNA
expression. Substrate flux representing either complete oxidation to CO2 or partial
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oxidation to ketone bodies was depressed by saturated fatty acids and these fluxes both
correlate with PCK1 mRNA expression. Activation of enzymes involved in ketogenesis
or gluconeogenesis, including PCK, may be tempered by inclusion of factors that
specifically activate PC, while only maintaining PCK to promote cellular oxidative
capacity.
Activity of bovine PCP1 was directly examined in response to saturated and
unsaturated fatty acid treatments using a promoter reporter construct and nested 5’ serial
promoter truncations. Bovine PCP1 activity increased after exposure to either unsaturated
C18:3n-3 cis or saturated 16:0 treatments. Promoter truncation experiments evaluating
specific regions of bovine PCP1 reveal a region between -773 to -494 bp (bovine PCP1(773_+3))

relative to transcription start site (TSS) that is highly responsive to fatty acids. In

silico analysis of bovine PCP1 showed several transcription factor binding site consensus
sequences within this region. Bovine PCP1 response to the presence of C18:3n-3 cis may
be due to potential signaling through peroxisome proliferator activated receptor (PPAR) α
at potential binding sites within bovine PCP1(-1002_+3) or within bovine bovine PCP1(222_+3).

A lack of response to C18:3n-3 cis of bovine PCP1(-494_+3) may be linked to sterol

regulatory element binding proteins (SREBP) binding sites, which are responsive to
saturated fatty acids. A more rigorous evaluation of these putative transcription factor
binding sites is necessary to definitively assign these elements to control of the bovine PC
gene.
Taken together, these data indicate that bovine PC mRNA expression is
responsive to fatty acids through changes in the activity of the PC proximal promoter.
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Furthermore, PC mRNA expression is correlated with complete substrate oxidation to
CO2, supporting the potential role for PC flux to promote cellular oxidative capacity.
This new research adds to our knowledge of the balance between anaplerosis and
cataplerosis and the response to metabolic conditions by PC. This information provides
new insight that may be applied to better understand the physiological response of dairy
cows to the onset of lactation and potential changes in hepatic oxidative capacity during
this interval. Nonesterified fatty acids (NEFA) that are mobilized during periods of
negative energy balance, including the periparturient period in dairy cattle, are taken up
by liver and subsequently are either completely or partially oxidized. The current work
confirms that the fates of NEFA are determined, in part, by PC activity thus promoting
the pull of acetyl-CoA through the TCA cycle for complete oxidation (Figure 5.1).
Because it is also well established that acetyl-CoA serves as an allosteric regulator of PC,
and the current data effectively demonstrate the influence that fatty acids have in
determining both PC mRNA expression and substrate pull towards oxidation. If the
availability of acetyl-CoA is greater than the supply of OAA, excess acetyl-CoA will be
incompletely oxidized to ketone bodies. This puts a periparturient dairy cow at increased
risk for developing ketosis if PC activity cannot maintain the OAA pool. Novel findings
from the current research illustrate the pivotal role for PC in the anaplerotic generation of
TCA cycle intermediates, and emphasize the importance of identifying potential factors
that specifically promote PC flux while only maintaining but not expanding the pull, by
PCK, of carbons for gluconeogenesis. If the ratio of PCK : PC increases, carbon flux will
be promoted to gluconeogenesis rather than into the TCA cycle. Bovine PCP1 is
responsive to the same physiological factors, primarily circulating fatty acids, which
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dramatically increase during the negative energy balance experienced by dairy cattle
during the periparturient period.
Data in this dissertation demonstrates for the first time that the response of PC
mRNA expression, through bovine PCP1 promoter activity, is dependent on the ratio of
saturated to unsaturated fatty acids, with polyunsaturated n-3 fatty acid having strong
stimulatory influence. Additional work is necessary to translate this fundamental
discovery to application but the potential exists, based on the present data, to program
hepatic metabolism in transition cows towards enhanced capacity to metabolize NEFA in
favor of complete and partial oxidation and alleviate the potential for hepatic lipid
accumulation that is prevalent in the industry. Manipulation of the ratio of fatty acids in
plasma through feeding management strategies during critical periods of metabolic stress,
if successful, may favor a shift in hepatic metabolism that would aid in the prevention of
metabolic disorders in dairy cows. While the present work has focused on lipid
metabolism in gluconeogenic tissues, it will be critical going forward to determine the
impact of manipulating fatty acid profiles more holistically in the dairy cow and the
overall impact on animal health and productivity.
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Figure 5.1. A diagram of fatty acid metabolism in dairy cows and impact of pyruvate
carboxylase (PC). Nonesterified fatty acids (NEFA) are mobilized from adipose tissue
reserves during periods of negative energy balance, including the periparturient period in
dairy cows. Metabolized NEFA can have several fates, including esterification and
deposition as liver triglycerides (TG), partial oxidation, yielding ketones, or complete
oxidation of acetyl-CoA to ATP and CO2. The capacity of the tricarboxylic acid (TCA)
cycle to oxidize acetyl-CoA is dependent upon the available pool of oxaloacetate (OAA).
The anaplerotic regeneration of TCA cycle intermediates is supported by PC, which
catalyzes the conversion of pyruvate to OAA. If PC activity increases, supply of OAA to
the TCA cycle can be increased, only if the activity of phosphoenolpyruvate

144
carboxykinase (PCK) is maintained, but not concurrently increased. Expression of PC
mRNA is, in part, regulated by the profile of fatty acids present, with specific effects of
saturated fatty acids (C16:0 or C18:0) to depress PC mRNA expression, which can be
recovered with exposure to polyunsaturated C18:3n-3 cis. This change in PC mRNA
expression directly correlates to the partitioning of C16:0 to CO2, or a laboratory
measurement of ketones. Fatty acids may act to further regulate cellular metabolism by
activating transcription factors with response elements in the bovine PC proximal
promoter, further potentiating the response of PC to fatty acids. Cytosolic
phosphoenolpyruvate carboxykinase, PCK1; mitochondrial phosphoenolpyruvate
carboxykinase, PCK2; phosphoenolpyruvate, PEP.
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